Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

[1]  C. Baker,et al.  Red book®: 2003 report of the committee on infectious diseases. , 2016 .

[2]  Joan Webster,et al.  Gauze and tape and transparent polyurethane dressings for central venous catheters. , 2016, The Cochrane database of systematic reviews.

[3]  L. Leibovici,et al.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients. , 2014, The Cochrane database of systematic reviews.

[4]  C. Glen Mayhall,et al.  Hospital Epidemiology and Infection Control , 2011 .

[5]  H. Einsele,et al.  Immune response to the 23-valent polysaccharide pneumococcal vaccine after the 7-valent conjugate vaccine in allogeneic stem cell transplant recipients: results from the EBMT IDWP01 trial. , 2010, Vaccine.

[6]  A. Zelenetz,et al.  Pertussis immunity and response to tetanus-reduced diphtheria-reduced pertussis vaccine (Tdap) after autologous peripheral blood stem cell transplantation. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  P. Murray,et al.  A Cluster of Cases of Nosocomial Legionnaires Disease Linked to a Contaminated Hospital Decorative Water Fountain , 2009, Infection Control & Hospital Epidemiology.

[8]  H. Atkins,et al.  Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research. , 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[9]  J. Timsit,et al.  Chlorhexidine-impregnated sponges and less frequent dressing changes for prevention of catheter-related infections in critically ill adults: a randomized controlled trial. , 2009, JAMA.

[10]  P. Gastmeier,et al.  Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial , 2009, Annals of Hematology.

[11]  Roger I Glass,et al.  Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2009, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[12]  D. Weisdorf,et al.  Fewer infections and lower infection-related mortality following non-myeloablative versus myeloablative conditioning for allotransplantation of patients with lymphoma , 2009, Bone Marrow Transplantation.

[13]  G. Garcia-Manero,et al.  Randomized comparison of cooked and noncooked diets in patients undergoing remission induction therapy for acute myeloid leukemia. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  A. Scaradavou,et al.  Immunogenicity of the Tetravalent Protein-Conjugated Meningococcal Vaccine in Recipients of Related and Unrelated Allogeneic Hematopoietic Cell Transplants (HCT) , 2008 .

[15]  James W. Young,et al.  Use of the Tetanus Toxoid, Reduced Dose Diphtheria and Pertussis Vaccine (Tdap) in Allogeneic Transplant (alloHCT) Recipients. , 2008 .

[16]  H. Einsele,et al.  Immune Response to the 23-Valent Polysaccharide Pneumococcal Vaccine (PPV23) after the 7-Valent Conjugate Vaccine (PCV7) in Allogeneic Stem Cell Transplant (SCT) Recipients: Results of the EBMT IDWP01 Trial , 2008 .

[17]  L. Zhao,et al.  Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. , 2008, The New England journal of medicine.

[18]  R. Khabbaz.  National Center for Preparedness, Detection, and Control of Infectious Diseases , 2008 .

[19]  M. Boeckh,et al.  An Outbreak of Varicella with Likely Breakthrough Disease in a Population of Pediatric Cancer Patients , 2008, Infection Control & Hospital Epidemiology.

[20]  S. Raza,et al.  The stem cell transplant program in Pakistan—the first decade , 2008, Bone Marrow Transplantation.

[21]  S. Yamasaki,et al.  Infectious complications in chronic graft‐versus‐host disease: a retrospective study of 145 recipients of allogeneic hematopoietic stem cell transplantation with reduced‐ and conventional‐intensity conditioning regimens , 2008, Transplant infectious disease : an official journal of the Transplantation Society.

[22]  S. Chou.  Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir , 2008, Reviews in medical virology.

[23]  S. Ansell,et al.  Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[24]  I. Alevizos,et al.  Oral graft-versus-host disease. , 2008, Oral diseases.

[25]  Patricia Muñoz,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  C. Hanlon,et al.  Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices. , 2008, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[27]  T. Palmore,et al.  Transfusion-associated babesiosis with an atypical time course after nonmyeloablative transplantation for sickle cell disease. , 2008, Annals of internal medicine.

[28]  W. Hop,et al.  Aerosolized liposomal amphotericin B for the prevention of invasive pulmonary aspergillosis during prolonged neutropenia: a randomized, placebo-controlled trial. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  M. Shen.  Diagnostic and Therapeutic Challenges of Childhood Brucellosis in a Nonendemic Country , 2008, Pediatrics.

[30]  J. Storek.  Immunological reconstitution after hematopoietic cell transplantation – its relation to the contents of the graft , 2008 .

[31]  P. Nordmann,et al.  Is plasmid-mediated quinolone resistance a clinically significant problem? , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[32]  Hugo Sax,et al.  Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. , 2008, JAMA.

[33]  Xiao-jun Huang,et al.  Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[34]  F. Aversa,et al.  Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States , 2008, Bone Marrow Transplantation.

[35]  P. LaRussa,et al.  The safety profile of varicella vaccine: a 10-year review. , 2008, The Journal of infectious diseases.

[36]  B. Gruhn,et al.  Monitoring of Epstein‐Barr virus load after hematopoietic stem cell transplantation for early intervention in post‐transplant lymphoproliferative disease , 2008, Journal of medical virology.

[37]  M. Chamberlain,et al.  POST-TRANSPLANT ACUTE LIMBIC ENCEPHALITIS: CLINICAL FEATURES AND RELATIONSHIP TO HHV6 , 2008, Neurology.

[38]  R. Tauxe,et al.  Juice-associated outbreaks of human illness in the United States, 1995 through 2005. , 2008, Journal of food protection.

[39]  C. Donskey,et al.  Clostridium difficile skin contamination in patients with C. difficile-associated disease. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  G. Srkalović,et al.  Mycobacterium avium Complex Infection After Alemtuzumab Therapy for Chronic Lymphocytic Leukemia , 2008, Pharmacotherapy.

[41]  S. Goyal,et al.  In-vivo efficacy of hand sanitisers against feline calicivirus: a surrogate for norovirus. , 2008, The Journal of hospital infection.

[42]  A. Gratwohl,et al.  Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[43]  M. Jackson,et al.  Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings 2007 , 2008 .

[44]  Z. Gulay,et al.  qnrA prevalence in extended-spectrum beta-lactamase-positive Enterobacteriaceae isolates from Turkey. , 2008, Japanese journal of infectious diseases.

[45]  Thierry Buclin,et al.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  J. Faoagali,et al.  Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: Results from a prospective trial , 2008, Scandinavian journal of infectious diseases.

[47]  E. Shpall,et al.  Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing. , 2007, Blood.

[48]  Deepali Kumar,et al.  A randomized, double-blind trial of pneumococcal vaccination in adult allogeneic stem cell transplant donors and recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  M. Ghannoum,et al.  Breakthrough invasive aspergillosis in allogeneic haematopoietic stem cell transplant recipients treated with caspofungin. , 2007, International journal of antimicrobial agents.

[50]  P. Chandrasekar,et al.  Pharmacokinetics of Oral Posaconazole in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Graft‐versus‐Host Disease , 2007, Pharmacotherapy.

[51]  J. Blahova,et al.  Four Years of Monitoring Antibiotic Resistance in Microorganisms from Bacteremic Patients , 2007, Journal of chemotherapy.

[52]  M. Jackson,et al.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings , 2007, American Journal of Infection Control.

[53]  M. Jackson,et al.  Management of multidrug-resistant organisms in health care settings, 2006. , 2007, American journal of infection control.

[54]  J. Dipersio,et al.  Results of a Randomized, Double-Blind Trial of Fluconazole (FLU) vs. Voriconazole (VORI) for the Prevention of Invasive Fungal Infections (IFI) in 600 Allogeneic Blood and Marrow Transplant (BMT) Patients. , 2007 .

[55]  Y. Obase,et al.  Clinical evaluation of QuantiFERON TB-2G test for immunocompromised patients , 2007, European Respiratory Journal.

[56]  K. Marr,et al.  Risks, diagnosis and outcomes of invasive fungal infections in haematopoietic stem cell transplant recipients , 2007, British journal of haematology.

[57]  K. Weinberg,et al.  Immunological Reconstitution Following Hematopoietic Cell Transplantation , 2007 .

[58]  I. Carneiro,et al.  Plant based insect repellent and insecticide treated bed nets to protect against malaria in areas of early evening biting vectors: double blind randomised placebo controlled clinical trial in the Bolivian Amazon , 2007, BMJ : British Medical Journal.

[59]  T. Stevens-Ayers,et al.  Quantitative real-time polymerase chain reaction for detection of adenovirus after T cell-replete hematopoietic cell transplantation: viral load as a marker for invasive disease. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[60]  R. Porcher,et al.  Palivizumab treatment of respiratory syncytial virus infection after allogeneic hematopoietic stem cell transplantation. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[61]  K. Takenaka,et al.  Toxoplasmosis encephalitis following severe graft‐vs.‐host disease after allogeneic hematopoietic stem cell transplantation: 17 yr experience in Fukuoka BMT group , 2007, European journal of haematology.

[62]  N. Kröger,et al.  Autologous stem cell transplantation in myelodysplastic syndromes. , 2007, Seminars in hematology.

[63]  J. Passweg,et al.  Autologous stem cell transplantation in autoimmune diseases. , 2007, Seminars in hematology.

[64]  F. Baldanti,et al.  Use of a DNAemia cut-off for monitoring human cytomegalovirus infection reduces the number of preemptively treated children and young adults receiving hematopoietic stem-cell transplantation compared with qualitative pp65 antigenemia. , 2007, Blood.

[65]  K. Rezvani,et al.  Absolute lymphocyte count on day 30 is a surrogate for robust hematopoietic recovery and strongly predicts outcome after T cell-depleted allogeneic stem cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[66]  G. Gahrton,et al.  High-dose treatment with autologous stem cell transplantation in multiple myeloma: past, present, and future. , 2007, Seminars in hematology.

[67]  P. Nathan,et al.  Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection , 2007, Annals of Internal Medicine.

[68]  S. Holland,et al.  Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[69]  P. Vanhems,et al.  Reduction of invasive aspergillosis incidence among immunocompromised patients after control of environmental exposure. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[70]  L. Leibovici,et al.  Prophylaxis of Pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. , 2007, Mayo Clinic proceedings.

[71]  A. Streifel,et al.  Ten-year air sample analysis of Aspergillus prevalence in a university hospital. , 2007, The Journal of hospital infection.

[72]  J. Blair.  Coccidioidomycosis in Patients Who Have Undergone Transplantation , 2007, Annals of the New York Academy of Sciences.

[73]  L. Gordon,et al.  Breakthrough fungal infections after allogeneic hematopoietic stem cell transplantation in patients on prophylactic voriconazole , 2007, Bone Marrow Transplantation.

[74]  N. Glosson,et al.  Human herpesvirus-6A and -6B encode viral immunoevasins that downregulate class I MHC molecules. , 2007, Virology.

[75]  R. Munivenkatappa,et al.  Polyomavirus BK Versus JC Replication and Nephropathy in Renal Transplant Recipients: A Prospective Evaluation , 2007, Transplantation.

[76]  J. Cornelissen,et al.  Visceral leishmaniasis after allogeneic hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[77]  Melinda B Davis,et al.  A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[78]  E. Wong,et al.  Selective Use of Intranasal Mupirocin and Chlorhexidine Bathing and the Incidence of Methicillin-Resistant Staphylococcus aureus Colonization and Infection Among Intensive Care Unit Patients , 2007, Infection Control & Hospital Epidemiology.

[79]  W. Drew,et al.  Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients , 2007, Current opinion in infectious diseases.

[80]  Drew Wl.  Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. , 2007 .

[81]  P. Villiger,et al.  Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay , 2007, Annals of the rheumatic diseases.

[82]  M. Boeckh,et al.  Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[83]  W. Leisenring,et al.  Use of long-term suppressive acyclovir after hematopoietic stem-cell transplantation: impact on herpes simplex virus (HSV) disease and drug-resistant HSV disease. , 2007, The Journal of infectious diseases.

[84]  W. Leisenring,et al.  Fluconazole coadministration concurrent with cyclophosphamide conditioning may reduce regimen-related toxicity postmyeloablative hematopoietic cell transplantation. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[85]  L. Leibovici,et al.  Quinolone prophylaxis for bacterial infections in afebrile high risk neutropenic patients , 2007 .

[86]  K. Scott Baker,et al.  The management and outcome of chronic graft‐versus‐host disease , 2007, British journal of haematology.

[87]  D. R. Kockler,et al.  Zoster Vaccine Live , 2007, Pharmacotherapy.

[88]  V. Anttila,et al.  The utility of intensified environmental surveillance for pathogenic moulds in a stem cell transplantation ward during construction work to monitor the efficacy of HEPA filtration , 2007, Bone Marrow Transplantation.

[89]  J. Seward,et al.  Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[90]  M. Somerfield,et al.  American Society of Clinical Oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[91]  J. Klein,et al.  Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study , 2007, The Lancet.

[92]  V. Yu,et al.  Role of Environmental Surveillance in Determining the Risk of Hospital-Acquired Legionellosis: A National Surveillance Study With Clinical Correlations , 2007, Infection Control & Hospital Epidemiology.

[93]  M. Pfaller,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing , 2007, Journal of Clinical Microbiology.

[94]  J. Aschan.  Risk assessment in haematopoietic stem cell transplantation: conditioning. , 2007, Best practice & research. Clinical haematology.

[95]  A. Kressel,et al.  Construction: a model program for infection control compliance. , 2007, American journal of infection control.

[96]  Alvaro Urbano-Ispizua,et al.  Risk assessment in haematopoietic stem cell transplantation: stem cell source. , 2007, Best practice & research. Clinical haematology.

[97]  E. Petersdorf.  Risk assessment in haematopoietic stem cell transplantation: histocompatibility. , 2007, Best practice & research. Clinical haematology.

[98]  D. Perlin.  Resistance to echinocandin-class antifungal drugs. , 2007, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[99]  A. Chaidos,et al.  Risk assessment in haemotopoietic stem cell transplantation: disease and disease stage. , 2007, Best practice & research. Clinical haematology.

[100]  H. Heslop,et al.  Reconstitution of adenovirus-specific cell-mediated immunity in pediatric patients after hematopoietic stem cell transplantation , 2007, Bone Marrow Transplantation.

[101]  F. Locatelli,et al.  Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[102]  F. Dazzi,et al.  Disease relapse after haematopoietic stem cell transplantation: risk factors and treatment. , 2007, Best practice & research. Clinical haematology.

[103]  G. Papanicolaou,et al.  Invasive adenoviral infections in T‐cell‐depleted allogeneic hematopoietic stem cell transplantation: high mortality in the era of cidofovir , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[104]  I. Tezcan,et al.  Tuberculin skin test positivity in pediatric allogeneic BMT recipients and donors in Turkey , 2007, Pediatric transplantation.

[105]  A. Dickinson.  Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics. , 2007, Best practice & research. Clinical haematology.

[106]  A. Wald,et al.  One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation. , 2007, Blood.

[107]  B. Danuser,et al.  Occupational risk assessment of aspergillosis after renal transplantation , 2007, Transplant infectious disease : an official journal of the Transplantation Society.

[108]  D. Paterson,et al.  Risk factors, clinical characteristics, and outcome of Nocardia infection in organ transplant recipients: a matched case-control study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[109]  J. V. van Burik,et al.  Infectious complications following unrelated cord blood transplantation , 2007, Vox sanguinis.

[110]  D. Stark,et al.  Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course. , 2007, Journal of medical microbiology.

[111]  Y. Kanda,et al.  Cytomegalovirus infections following umbilical cord blood transplantation using reduced intensity conditioning regimens for adult patients. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[112]  M. Serrano,et al.  Pulmonary nocardiosis: Risk factors and outcomes , 2007, Respirology.

[113]  S. Saidman,et al.  Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen , 2007, Bone Marrow Transplantation.

[114]  J. Meis,et al.  Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2005: an 8.5-Year Analysis of Susceptibilities of Candida Species and Other Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing , 2007, Journal of Clinical Microbiology.

[115]  A. Dietz,et al.  Sterility testing of hematopoietic progenitor cell products: a single‐institution series of culture‐positive rates and successful infusion of culture‐positive products , 2007, Transfusion.

[116]  J. Schwartz,et al.  Microbial pathogens of hematopoietic stem cells – screening and testing for infectious diseases , 2007 .

[117]  W. Murphy,et al.  Immunobiology of allogeneic hematopoietic stem cell transplantation. , 2007, Annual review of immunology.

[118]  A. Linhares,et al.  Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy infants. , 2007, Jornal de pediatria.

[119]  C. Kotton,et al.  Zoonoses in solid-organ and hematopoietic stem cell transplant recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[120]  C. Ohmann,et al.  Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation. , 2007, Blood.

[121]  M. Pai,et al.  Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for Research , 2007, Annals of Internal Medicine.

[122]  R. Borrow,et al.  Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[123]  D. McGuire,et al.  Clinical Practice Guidelines for the Prevention and Treatment of Mucositis , 2007 .

[124]  S. Giralt.  Allogeneic hematopoietic progenitor cell transplantation for the treatment of chronic myelogenous leukemia in the era of tyrosine kinase inhibitors: lessons learned to date. , 2007, Clinical lymphoma & myeloma.

[125]  R. Storb,et al.  Hematopoietic cell transplantation after reduced-intensity conditioning for older adults with acute myeloid leukemia in complete remission , 2007, Current opinion in hematology.

[126]  R. Champlin,et al.  Streptococcus pneumoniae Infections in 47 Hematopoietic Stem Cell Transplantation Recipients: Clinical Characteristics of Infections and Vaccine-Breakthrough Infections, 1989-2005 , 2007, Medicine.

[127]  Hans H Hirsch,et al.  Antivirals for the treatment of polyomavirus BK replication , 2007, Expert review of anti-infective therapy.

[128]  P. Hari,et al.  Suppressive Anti-HCV Therapy for Prevention of Donor to Recipient Transmission in Stem Cell Transplantation , 2007, The American Journal of Gastroenterology.

[129]  G. Mufti,et al.  Toxoplasmosis following alemtuzumab based allogeneic haematopoietic stem cell transplantation. , 2007, The Journal of infection.

[130]  E. Guinan,et al.  An update on the management of severe idiopathic aplastic anaemia in children , 2007, British journal of haematology.

[131]  J. Lipton,et al.  Posaconazole or fluconazole for prophylaxis in severe graft-versus-host disease. , 2007, The New England journal of medicine.

[132]  J. Burke,et al.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[133]  M. Boeckh,et al.  Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[134]  A. Tan,et al.  Molecular features of astrovirus associated with a gastroenteritis outbreak in an aged-care centre , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[135]  H. Harputluoglu,et al.  Rituximab-related viral infections in lymphoma patients , 2007, Leukemia & lymphoma.

[136]  P. Pronovost,et al.  An intervention to decrease catheter-related bloodstream infections in the ICU. , 2006, The New England journal of medicine.

[137]  N. Schmitz,et al.  Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. , 2006, Blood.

[138]  P. Murray,et al.  Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR‐compliant method , 2006, Transfusion.

[139]  G. Mufti,et al.  Lamivudine prophylaxis and treatment of hepatitis B Virus‐exposed recipients receiving reduced intensity conditioning hematopoietic stem cell transplants with alemtuzumab , 2006, Journal of medical virology.

[140]  J. Dipersio,et al.  Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? , 2006, Bone Marrow Transplantation.

[141]  J. Passweg,et al.  Comparison of long-term outcomes after allogeneic hematopoietic stem cell transplantation from matched sibling and unrelated donors , 2006, Bone Marrow Transplantation.

[142]  Z. Bisoffi,et al.  Evaluation of an Indirect Immunofluorescence Assay for Strongyloidiasis as a Tool for Diagnosis and Follow-Up , 2006, Clinical and Vaccine Immunology.

[143]  L. Dupuis,et al.  Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[144]  M. Boeckh.  Prevention of VZV infection in immunosuppressed patients using antiviral agents. , 2006, Herpes : the journal of the IHMF.

[145]  D. Kadidlo,et al.  Microbial contamination of hematopoietic stem cell products: incidence and clinical sequelae. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[146]  N. Pace,et al.  Relationships between Mycobacterium Isolates from Patients with Pulmonary Mycobacterial Infection and Potting Soils , 2006, Applied and Environmental Microbiology.

[147]  T. Kosatsky,et al.  Exposure to aerosolized bacteria and fungi among collectors of commercial, mixed residential, recyclable and compostable waste. , 2006, The Science of the total environment.

[148]  Richard Platt,et al.  Impact of routine intensive care unit surveillance cultures and resultant barrier precautions on hospital-wide methicillin-resistant Staphylococcus aureus bacteremia. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[149]  K. Goldman.  Dental management of patients with bone marrow and solid organ transplantation. , 2006, Dental clinics of North America.

[150]  L. Dong,et al.  Surveillance of Active Human Herpesvirus 6 Infection in Chinese Patients after Hematopoietic Stem Cell Transplantation with 3 Different Methods , 2006, International journal of hematology.

[151]  E. Gluckman,et al.  Donor selection for unrelated cord blood transplants. , 2006, Current opinion in immunology.

[152]  F. Baron,et al.  Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning , 2006, Leukemia.

[153]  A. Robicsek,et al.  The worldwide emergence of plasmid-mediated quinolone resistance. , 2006, The Lancet. Infectious diseases.

[154]  K. Sepkowitz,et al.  Postexposure prophylaxis against varicella zoster virus infection among hematopoietic stem cell transplant recipients. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[155]  R. Will,et al.  Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study , 2006, BMJ.

[156]  Francisco Cervantes,et al.  Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. , 2006, Blood.

[157]  M. Keating,et al.  Respiratory Viral Infections in Adults With Hematologic Malignancies and Human Stem Cell Transplantation Recipients: A Retrospective Study at a Major Cancer Center , 2006, Medicine.

[158]  J. Wingard,et al.  New strategies of antifungal therapy in hematopoietic stem cell transplant recipients and patients with hematological malignancies. , 2006, Blood reviews.

[159]  Ronald N. Jones,et al.  Influence of patient age on the frequency of occurrence and antimicrobial resistance patterns of isolates from hematology/oncology patients: report from the Chemotherapy Alliance for Neutropenics and the Control of Emerging Resistance Program (North America). , 2006, Diagnostic microbiology and infectious disease.

[160]  Dan M. Kluger,et al.  The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. , 2006, Mayo Clinic proceedings.

[161]  D. Maki,et al.  Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[162]  F. Lucht,et al.  Efficacy of environmental measures to decrease the risk of hospital-acquired aspergillosis in patients hospitalised in haematology wards. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[163]  G. McDonald.  Review article: management of hepatic disease following haematopoietic cell transplant , 2006, Alimentary pharmacology & therapeutics.

[164]  P. L. Bergsagel,et al.  Mayo clinic consensus statement for the use of bisphosphonates in multiple myeloma. , 2006, Mayo Clinic proceedings.

[165]  M. Ison,et al.  Adenovirus infections in transplant recipients. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[166]  T. Lion,et al.  Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation , 2006, British journal of haematology.

[167]  P. Gastmeier,et al.  Nosocomial aspergillosis in outbreak settings. , 2006, The Journal of hospital infection.

[168]  A. Gorelik,et al.  A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients , 2006, Bone Marrow Transplantation.

[169]  A. Razmpour,et al.  A Randomized, Double-Blind Study of the Safety, Transmissibility and Phenotypic and Genotypic Stability of Cold-Adapted Influenza Virus Vaccine , 2006, The Pediatric infectious disease journal.

[170]  P. Pedrazzoli,et al.  Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[171]  S. Cameron,et al.  Does using potting mix make you sick? Results from a Legionella longbeachae case-control study in South Australia , 2006, Epidemiology and Infection.

[172]  D. Roy,et al.  What is the clinical significance of infusing hematopoietic cell grafts contaminated with bacteria? , 2006, Bone Marrow Transplantation.

[173]  L. Elting,et al.  Bisphosphonate-associated osteonecrosis: a long-term complication of bisphosphonate treatment. , 2006, The Lancet. Oncology.

[174]  D. Stevens,et al.  Who let the dogs out? Infection control did: utility of dogs in health care settings and infection control aspects. , 2006, American journal of infection control.

[175]  R. Black,et al.  Efficacy of probiotics in prevention of acute diarrhoea: a meta-analysis of masked, randomised, placebo-controlled trials. , 2006, The Lancet. Infectious diseases.

[176]  N. Lee,et al.  Rapid helper T-cell recovery above 200 × 106/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation , 2006, Bone Marrow Transplantation.

[177]  D. Srivastava,et al.  Cidofovir for the Treatment of Adenoviral Infection in Pediatric Hematopoietic Stem Cell Transplant Patients , 2006, Transplantation.

[178]  B. Bell,et al.  Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[179]  G. Rogler,et al.  Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. , 2006, Blood.

[180]  J. Randle,et al.  Toys--friend or foe? A study of infection risk in a paediatric intensive care unit. , 2006, Paediatric nursing.

[181]  H. Humphreys,et al.  Guidelines for the control and prevention of meticillin-resistant Staphylococcus aureus (MRSA) in healthcare facilities. , 2006, The Journal of hospital infection.

[182]  S. Ansell,et al.  Early lymphocyte recovery after autologous stem cell transplantation predicts superior survival in mantle-cell lymphoma , 2006, Bone Marrow Transplantation.

[183]  J. Perkins,et al.  Valganciclovir is safe and effective as pre-emptive therapy for CMV infection in allogeneic hematopoietic stem cell transplantation , 2006, Bone Marrow Transplantation.

[184]  G. Ridgway,et al.  Gastrointestinal endoscopy decontamination failure and the risk of transmission of blood-borne viruses: a review. , 2006, The Journal of hospital infection.

[185]  J. Boyce,et al.  Lack of Association Between the Increased Incidence of Clostridium difficile–Associated Disease and the Increasing Use of Alcohol-Based Hand Rubs , 2006, Infection Control & Hospital Epidemiology.

[186]  M. Sidhu,et al.  Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting. , 2006, Virology.

[187]  R. Schwartz,et al.  MR imaging of human herpesvirus-6-associated encephalitis in 4 patients with anterograde amnesia after allogeneic hematopoietic stem-cell transplantation. , 2006, AJNR. American journal of neuroradiology.

[188]  P. Griffiths,et al.  Human Herpesvirus 6 Chromosomal Integration in Immunocompetent Patients Results in High Levels of Viral DNA in Blood, Sera, and Hair Follicles , 2006, Journal of Clinical Microbiology.

[189]  L. Gerber,et al.  Ancillary therapy and supportive care of chronic graft-versus-host disease: national institutes of health consensus development project on criteria for clinical trials in chronic Graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[190]  H. Einsele,et al.  Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation. , 2006, Blood.

[191]  M. Sobsey,et al.  Efficacy of Hospital Germicides against Adenovirus 8, a Common Cause of Epidemic Keratoconjunctivitis in Health Care Facilities , 2006, Antimicrobial Agents and Chemotherapy.

[192]  O. Akan,et al.  Tuberculosis in stem cell transplant patients. , 2006, The Journal of hospital infection.

[193]  R. Willemze,et al.  Oral valganciclovir as pre-emptive therapy has similar efficacy on cytomegalovirus DNA load reduction as intravenous ganciclovir in allogeneic stem cell transplantation recipients , 2006, Bone Marrow Transplantation.

[194]  M. Boccadoro,et al.  Kaposi's sarcoma triggered by endogenous HHV‐8 reactivation after non‐myeloablative allogeneic haematopoietic transplantation , 2006, European journal of haematology.

[195]  M. Boeckh,et al.  Brief Communication: Fatal Human Metapneumovirus Infection in Stem-Cell Transplant Recipients , 2006, Annals of Internal Medicine.

[196]  M. Boeckh,et al.  Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study. , 2006, Blood.

[197]  K. Rezvani,et al.  Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia. , 2006, Blood.

[198]  A. Gennery,et al.  Environmental Monitoring for Gastroenteric Viruses in a Pediatric Primary Immunodeficiency Unit , 2006, Journal of Clinical Microbiology.

[199]  G. Boivin,et al.  Effect of Ribavirin and Glucocorticoid Treatment in a Mouse Model of Human Metapneumovirus Infection , 2006, Antimicrobial Agents and Chemotherapy.

[200]  M. Boeckh,et al.  Immune monitoring with iTAg™ MHC tetramers for prediction of recurrent or persistent cytomegalovirus (CMV) infection in allogeneic stem cell transplant (SCT) recipients: A prospective multicenter clinical trial , 2006 .

[201]  T. Vesikari,et al.  Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. , 2006, The New England journal of medicine.

[202]  M. Turner,et al.  Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products , 2006, British journal of haematology.

[203]  Z. Samra,et al.  Catheter-Associated Bloodstream Infections in Pediatric Hematology-Oncology Patients: Factors Associated With Catheter Removal and Recurrence , 2006, Journal of pediatric hematology/oncology.

[204]  Ken Dewar,et al.  A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. , 2005, The New England journal of medicine.

[205]  Robin Patel,et al.  Emergence of quinolone resistance among viridans group streptococci isolated from the oropharynx of neutropenic peripheral blood stem cell transplant patients receiving quinolone antimicrobial prophylaxis , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[206]  R. Krance,et al.  Adenovirus infection rates in pediatric recipients of alternate donor allogeneic bone marrow transplants receiving either antithymocyte globulin (ATG) or alemtuzumab (Campath) , 2005, Bone Marrow Transplantation.

[207]  J. Blair,et al.  Coccidioidomycosis in hematopoietic stem cell transplant recipients. , 2005, Medical mycology.

[208]  R. Arceci,et al.  The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children: an evidence-based review. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[209]  F. Derouin,et al.  Occurrence of Pneumocystis jiroveci pneumonia after allogeneic stem cell transplantation: a 6-year retrospective study , 2005, Bone Marrow Transplantation.

[210]  A. Chatterjee,et al.  A modified "cover your cough" campaign prevents exposures of employees to pertussis at a children's hospital. , 2005, American journal of infection control.

[211]  A. Chybicka,et al.  Incidence, clinical outcome, and management of virus-induced hemorrhagic cystitis in children and adolescents after allogeneic hematopoietic cell transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[212]  G. Palù,et al.  Cidofovir for cytomegalovirus reactivation in pediatric patients after hematopoietic stem cell transplantation. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[213]  G. Morelli,et al.  Fluoroquinolone resistance in hematopoietic stem cell transplant recipients with infectious complications. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[214]  D. Weinstock,et al.  Active tuberculosis limited to foreign-born patients after allogeneic hematopoietic stem cell transplant , 2005, Bone Marrow Transplantation.

[215]  T. Asselah,et al.  Treatment of chronic hepatitis C virus in allogeneic bone marrow transplant recipients , 2005, Bone Marrow Transplantation.

[216]  H. Lawson,et al.  Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2007, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[217]  Didier Pittet,et al.  Meticillin-resistant Staphylococcus aureus , 2005, The Lancet Infectious Diseases.

[218]  R. Foà,et al.  Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. , 2005, The New England journal of medicine.

[219]  D. Goldmann,et al.  A Randomized, Controlled Trial of a Multifaceted Intervention Including Alcohol-Based Hand Sanitizer and Hand-Hygiene Education to Reduce Illness Transmission in the Home , 2005, Pediatrics.

[220]  I. Hussain,et al.  Role of isoniazid prophylaxis for prevention of tuberculosis in haemopoietic stem cell transplant recipients. , 2005, JPMA. The Journal of the Pakistan Medical Association.

[221]  M. Edmond,et al.  Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[222]  P. Veys,et al.  Improved outcome for children with disseminated adenoviral infection following allogeneic stem cell transplantation , 2005, British journal of haematology.

[223]  S. Sattar,et al.  Activity of selected oxidizing microbicides against the spores of Clostridium difficile: relevance to environmental control. , 2005, American journal of infection control.

[224]  C. Craddock,et al.  Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers , 2005, The Journal of experimental medicine.

[225]  V. Yu,et al.  A proactive approach to prevention of health care-acquired Legionnaires' disease: the Allegheny County (Pittsburgh) experience. , 2005, American journal of infection control.

[226]  J. Barbara,et al.  Documented cases of post‐transfusion malaria occurring in England: a review in relation to current and proposed donor‐selection guidelines , 2005, Vox sanguinis.

[227]  C. Robertson,et al.  Comparison of Antimicrobial Impregnation With Tunneling of Long-term Central Venous Catheters: A Randomized Controlled Trial , 2005, Annals of surgery.

[228]  A. Gennery,et al.  Use of a Heminested Reverse Transcriptase PCR Assay for Detection of Astrovirus in Environmental Swabs from an Outbreak of Gastroenteritis in a Pediatric Primary Immunodeficiency Unit , 2005, Journal of Clinical Microbiology.

[229]  John Painter,et al.  Effect of handwashing on child health: a randomised controlled trial , 2005, The Lancet.

[230]  C. Machado.  Influenza infections after hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[231]  W. Au,et al.  A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. , 2005, Blood.

[232]  G. Palù,et al.  Human herpesvirus 8 DNA in serum during seroconversion in allogeneic bone marrow transplant recipients. , 2005, Journal of the National Cancer Institute.

[233]  E. Claas,et al.  Adenovirus infection in paediatric stem cell transplant recipients: increased risk in young children with a delayed immune recovery , 2005, Bone Marrow Transplantation.

[234]  B. Storer,et al.  Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation: a case-control study. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[235]  M. Pinheiro,et al.  Outbreak of Extended Spectrum β-Lactamase-Producing Klebsiella pneumoniae Infection in a Neonatal Intensive Care Unit Related to Onychomycosis in a Health Care Worker , 2005, The Pediatric infectious disease journal.

[236]  J. Altclas,et al.  Chagas disease in bone marrow transplantation: an approach to preemptive therapy , 2005, Bone Marrow Transplantation.

[237]  R. Scholten,et al.  Efficacy of oral prophylactic antibiotics in neutropenic afebrile oncology patients: a systematic review of randomised controlled trials. , 2005, European journal of cancer.

[238]  L. Leibovici,et al.  Meta-Analysis: Antibiotic Prophylaxis Reduces Mortality in Neutropenic Patients , 2005, Annals of Internal Medicine.

[239]  S. Mackinnon,et al.  The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation , 2005, Bone Marrow Transplantation.

[240]  R. Kamble,et al.  Microbial contamination of hematopoietic progenitor cell grafts—incidence, clinical outcome, and cost‐effectiveness: an analysis of 735 grafts , 2005, Transfusion.

[241]  J. Serody,et al.  Leukocyte migration and graft-versus-host disease. , 2005, Blood.

[242]  J. Tang,et al.  First Reported Outbreak of Diarrhea Due to Adenovirus Infection in a Hematology Unit for Adults , 2005, Journal of Clinical Microbiology.

[243]  G. Kampf,et al.  Efficacy of three ethanol-based hand rubs against feline calicivirus, a surrogate virus for norovirus. , 2005, The Journal of hospital infection.

[244]  Po-min Chen,et al.  Fatal Fulminant Hepatitis B after Withdrawal of Prophylactic Lamivudine in Hematopoietic Stem Cell Transplantation Patients , 2005, International journal of hematology.

[245]  H. Einsele,et al.  Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT , 2005, Bone Marrow Transplantation.

[246]  J. Salomon,et al.  Illness Transmission in the Home: A Possible Role for Alcohol-Based Hand Gels , 2005, Pediatrics.

[247]  A. Mijovic,et al.  Transfusion‐transmitted malaria: current donor selection guidelines are not sufficient , 2005, Vox sanguinis.

[248]  M. Boeckh,et al.  Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[249]  G. Filice.  Nocardiosis in persons with human immunodeficiency virus infection, transplant recipients, and large, geographically defined populations. , 2005, The Journal of laboratory and clinical medicine.

[250]  D. Dunn,et al.  Mycobacterial infections after kidney transplant. , 2005, Transplantation proceedings.

[251]  G. Lucarelli,et al.  Stem cell transplantation and gene therapy for hemoglobinopathies. , 2005, Current hematology reports.

[252]  R. Hershow,et al.  Aspergillus surveillance project at a large tertiary-care hospital. , 2005, The Journal of hospital infection.

[253]  M. Kalaycio,et al.  Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course , 2005, Bone Marrow Transplantation.

[254]  A. Wald,et al.  A population-based study of primary human herpesvirus 6 infection. , 2005, The New England journal of medicine.

[255]  Kwok-Hung Chan,et al.  Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[256]  C. Austin,et al.  Two Outbreaks of Occupationally Acquired Histoplasmosis: More than Workers at Risk , 2005, Environmental health perspectives.

[257]  W. Au,et al.  Sexual transmission of hepatitis B infection despite the presence of hepatitis B virus immunity in recipients of allogeneic bone marrow transplantation. , 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[258]  R. Handgretinger,et al.  Detection of adenovirus‐specific T cells in children with adenovirus infection after allogeneic stem cell transplantation , 2005, British journal of haematology.

[259]  G. Troché,et al.  Detection and Treatment of Antibiotic-Resistant Bacterial Carriage in a Surgical Intensive Care Unit: A 6-Year Prospective Survey , 2005, Infection Control & Hospital Epidemiology.

[260]  S. Riddell,et al.  Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[261]  S. Dupuis-Girod,et al.  In Vitro Susceptibility of Adenovirus to Antiviral Drugs is Species-Dependent , 2005, Antiviral therapy.

[262]  E. De Clercq,et al.  Update on Human Herpesvirus 6 Biology, Clinical Features, and Therapy , 2005, Clinical Microbiology Reviews.

[263]  K Leder,et al.  Respiratory infections during air travel , 2005, Internal medicine journal.

[264]  K. Bradstock,et al.  Tuberculosis in allogeneic stem cell transplant recipients: still a problem in the 21st century , 2004, Transplant infectious disease : an official journal of the Transplantation Society.

[265]  H. Nieuwenhuis,et al.  Low incidence of infectious complications after nonmyeloablative compared with myeloablative allogeneic stem cell transplantation , 2004, Transplant infectious disease : an official journal of the Transplantation Society.

[266]  W. Braun,et al.  Delirium in a renal transplant recipient associated with BK virus in the cerebrospinal fluid. , 2004, Transplantation.

[267]  J. Lipton,et al.  Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[268]  M. Boeckh,et al.  Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[269]  J. Radich,et al.  Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning. , 2004, Blood.

[270]  Lesley N Kerr,et al.  Assessment of the Durability of Medical Examination Gloves , 2004, Journal of occupational and environmental hygiene.

[271]  S. Rivella,et al.  Globin gene transfer for treatment of the β-thalassemias and sickle cell disease , 2004 .

[272]  N. Sebire,et al.  Pathology of astrovirus associated diarrhoea in a paediatric bone marrow transplant recipient , 2004, Journal of Clinical Pathology.

[273]  S. Cosgrove,et al.  Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. , 1997, MMWR. Morbidity and mortality weekly report.

[274]  H. Kantarjian,et al.  Long-term silicone central venous catheters impregnated with minocycline and rifampin decrease rates of catheter-related bloodstream infection in cancer patients: a prospective randomized clinical trial. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[275]  S. Nahirniak,et al.  Informed consent for blood transfusion: should the possibility of prion risk be included? , 2004, Transfusion medicine reviews.

[276]  M. Bard,et al.  Candida glabrata erg1 Mutant with Increased Sensitivity to Azoles and to Low Oxygen Tension , 2004, Antimicrobial Agents and Chemotherapy.

[277]  M. Pfaller,et al.  Geographic Variation in the Susceptibilities of Invasive Isolates of Candida glabrata to Seven Systemically Active Antifungal Agents: a Global Assessment from the ARTEMIS Antifungal Surveillance Program Conducted in 2001 and 2002 , 2004, Journal of Clinical Microbiology.

[278]  W. Rutala,et al.  The benefits of surface disinfection. , 2004, American journal of infection control.

[279]  T. Gutteberg,et al.  Hepatitis B virus‐infected peripheral blood progenitor cell harvests in liquid nitrogen freezer containing non‐infectious products , 2004, Transfusion.

[280]  N. Bae,et al.  Hickman catheter site infections after allogeneic stem cell transplantation: single-center experience. , 2004, Transplantation proceedings.

[281]  P. Murray,et al.  Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products. , 2004, Cytotherapy.

[282]  M. Betjes,et al.  Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[283]  C. Cordonnier,et al.  Secondary antifungal prophylaxis with voriconazole to adhere to scheduled treatment in leukemic patients and stem cell transplant recipients , 2004, Bone Marrow Transplantation.

[284]  D. McGuire,et al.  Clinical practice guidelines for the prevention and treatment of cancer therapy–induced oral and gastrointestinal mucositis , 2004, Cancer.

[285]  E. Anaissie,et al.  Fusarium infection in hematopoietic stem cell transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[286]  P. Ljungman,et al.  Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[287]  G. Antes,et al.  Does disinfection of environmental surfaces influence nosocomial infection rates? A systematic review. , 2004, American journal of infection control.

[288]  G. Lyon,et al.  Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999. , 2004, The American journal of tropical medicine and hygiene.

[289]  Xilin Yang,et al.  SARS Transmission, Risk Factors, and Prevention in Hong Kong , 2004, Emerging infectious diseases.

[290]  J. Steinmann.  Surrogate viruses for testing virucidal efficacy of chemical disinfectants , 2004, Journal of Hospital Infection.

[291]  Larry J. Anderson,et al.  Guidelines for preventing health-care-associated pneumonia, 2003 recommendations of the CDC and the Healthcare Infection Control Practices Advisory Committee. , 2004, Respiratory care.

[292]  C. Fegan,et al.  Incidence and outcome of adenovirus disease in transplant recipients after reduced-intensity conditioning with alemtuzumab. , 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[293]  Chi-kong Li,et al.  Ribavirin for Sars in Children , 2004, Clinical pediatrics.

[294]  E. Rosenberg,et al.  Detection of influenza antigen with rapid antibody-based tests after intranasal influenza vaccination (FluMist). , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[295]  L. Saiman,et al.  Outbreak of Extended-Spectrum Beta-Lactamase–Producing Klebsiella Pneumoniae in a Neonatal Intensive Care Unit Linked to Artificial Nails , 2004, Infection Control & Hospital Epidemiology.

[296]  J. Cassuto,et al.  Visceral leishmaniasis: a new opportunistic infection in hematopoietic stem-cell-transplanted patients , 2004, Bone Marrow Transplantation.

[297]  T. Asselah,et al.  Long-term outcome of hepatitis C infection after bone marrow transplantation. , 2004, Blood.

[298]  P Gastmeier,et al.  Surveillance of nosocomial infections , 2004 .

[299]  W. Leisenring,et al.  Itraconazole versus fluconazole for prevention of fungal infections in patients receiving allogeneic stem cell transplants. , 2004, Blood.

[300]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[301]  Joon-Oh Park,et al.  Tuberculosis in hematopoletk stem cell transplant recipients in Korea , 2004, International journal of hematology.

[302]  S. Horning,et al.  Rituximab as adjuvant to high-dose therapy and autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. , 2004, Blood.

[303]  R. Bakshi,et al.  MR imaging in toxoplasmosis encephalitis after bone marrow transplantation: paucity of enhancement despite fulminant disease. , 2004, AJNR. American journal of neuroradiology.

[304]  T. Nutman,et al.  Strongyloides stercoralis in the Immunocompromised Population , 2004, Clinical Microbiology Reviews.

[305]  B. Djulbegovic,et al.  Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[306]  G. Samonis,et al.  Clinical Experience With Minocycline and Rifampin-Impregnated Central Venous Catheters in Bone Marrow Transplantation Recipients: Efficacy and Low Risk of Developing Staphylococcal Resistance , 2003, Infection Control & Hospital Epidemiology.

[307]  U. Tirelli,et al.  High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[308]  Y. Kodera,et al.  Oral ribavirin for severe adenovirus infection after allogeneic marrow transplantation , 2003, Bone Marrow Transplantation.

[309]  L. Anderson,et al.  Active surveillance for respiratory virus infections in adults who have undergone bone marrow and peripheral blood stem cell transplantation , 2003, Bone Marrow Transplantation.

[310]  Y. Carlier,et al.  Congenital infection with Trypanosoma cruzi: from mechanisms of transmission to strategies for diagnosis and control. , 2003, Revista da Sociedade Brasileira de Medicina Tropical.

[311]  C. Mengoli,et al.  Reappraisal with meta-analysis of the addition of Gram-positive prophylaxis to fluoroquinolone in neutropenic patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[312]  F. Keller,et al.  Polyoma virus-associated interstitial nephritis in a patient with acute myeloic leukaemia and peripheral blood stem cell transplantation. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[313]  H. Tsutsumi,et al.  Pertussis in adolescence after unrelated cord blood transplantation , 2003, Bone Marrow Transplantation.

[314]  P. McMinn,et al.  Protective Isolation in Hemopoietic Stem Cell Transplants: A Review of the Literature and Single Institution Experience , 2003, Journal of pediatric oncology nursing : official journal of the Association of Pediatric Oncology Nurses.

[315]  P. Moss,et al.  Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines , 2003, The Lancet.

[316]  Cindy White,et al.  The effect of hand hygiene on illness rate among students in university residence halls. , 2003, American journal of infection control.

[317]  A. Cuzzocrea,et al.  Bone marrow failure associated with herpesvirus 8 infection in a patient undergoing autologous peripheral blood stem cell transplantation. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[318]  M. Maris,et al.  Immunologic recovery after hematopoietic cell transplantation with nonmyeloablative conditioning. , 2003, Experimental hematology.

[319]  H. Deeg,et al.  Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation , 2003, Bone Marrow Transplantation.

[320]  G. Boivin,et al.  Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. , 2003, Antiviral research.

[321]  F. Watzinger,et al.  Molecular monitoring of adenovirus in peripheral blood after allogeneic bone marrow transplantation permits early diagnosis of disseminated disease. , 2003, Blood.

[322]  R. Berkelman.  Human illness associated with use of veterinary vaccines. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[323]  M. Exner,et al.  Impact of portable air filtration units on exposure of haematology-oncology patients to airborne Aspergillus fumigatus spores under field conditions. , 2003, The Journal of hospital infection.

[324]  S. Dharmage,et al.  Influence of Building Construction Work On Aspergillus Infection in a Hospital Setting , 2003, Infection Control & Hospital Epidemiology.

[325]  F. Baldanti,et al.  Human cytomegalovirus immediate-early mRNAemia versus pp65 antigenemia for guiding pre-emptive therapy in children and young adults undergoing hematopoietic stem cell transplantation: a prospective, randomized, open-label trial. , 2003, Blood.

[326]  L. Sehulster,et al.  Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). , 2003, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[327]  J. Sejvar,et al.  Leptospirosis in “Eco-Challenge” Athletes, Malaysian Borneo, 2000 , 2003, Emerging infectious diseases.

[328]  M. Boeckh,et al.  Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood products. , 2003, Blood.

[329]  M. Territo,et al.  Intravenous and Oral Itraconazole versus Intravenous and Oral Fluconazole for Long-Term Antifungal Prophylaxis in Allogeneic Hematopoietic Stem-Cell Transplant Recipients: A Multicenter, Randomized Trial , 2003, Annals of Internal Medicine.

[330]  Carlene A. Muto,et al.  SHEA Guideline for Preventing Nosocomial Transmission of Multidrug-Resistant Strains of Staphylococcus aureus and Enterococcus , 2003, Infection Control & Hospital Epidemiology.

[331]  John H Rex,et al.  Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. , 2003, Blood.

[332]  D. Musher.  How contagious are common respiratory tract infections? , 2003, The New England journal of medicine.

[333]  William A Rutala,et al.  Efficacy of selected hand hygiene agents used to remove Bacillus atrophaeus (a surrogate of Bacillus anthracis) from contaminated hands. , 2003, JAMA.

[334]  J. Lipton,et al.  Systemic nocardiosis following allogeneic bone marrow transplantation , 2003, Transplant infectious disease : an official journal of the Transplantation Society.

[335]  W. G. Nichols,et al.  Transferred herpes simplex virus immunity after stem-cell transplantation: clinical implications. , 2003, The Journal of infectious diseases.

[336]  S. Trocciola,et al.  Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. , 2003, Blood.

[337]  P. Francioli,et al.  Risk for Pneumocystis carinii Transmission among Patients with Pneumonia: a Molecular Epidemiology Study , 2003, Emerging infectious diseases.

[338]  G. Hale,et al.  Immune reconstitution at 6 months following t-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome , 2002, Transplantation.

[339]  M. Gardam,et al.  Is surveillance for multidrug-resistant enterobacteriaceae an effective infection control strategy in the absence of an outbreak? , 2002, The Journal of infectious diseases.

[340]  A. Randolph,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2002, American journal of infection control.

[341]  M. Charlson,et al.  The Neutropenic Diet: What's the Evidence? , 2002, Journal of pediatric hematology/oncology.

[342]  R. Porcher,et al.  Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation. , 2002, Blood.

[343]  C. L. Fritz,et al.  Investigation of transfusion transmission of a WA1‐type babesial parasite to a premature infant in California , 2002, Transfusion.

[344]  R. Rubin,et al.  Clinical Approach to Infection in the Compromised Host , 2002, Springer US.

[345]  Didier Pittet,et al.  Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Dis , 2002, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[346]  E. Anaissie,et al.  Cleaning patient shower facilities: a novel approach to reducing patient exposure to aerosolized Aspergillus species and other opportunistic molds. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[347]  G. Lau,et al.  Prophylactic lamivudine therapy for hepatitis B patients undergoing immunosuppressive therapy. , 2002, Blood.

[348]  K. Yamanishi,et al.  High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. , 2002, Blood.

[349]  D. Ho,et al.  Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations. , 2002, Blood.

[350]  J. Duchin,et al.  The role of person-to-person transmission in an epidemiologic study of Pneumocystis carinii pneumonia , 2002, AIDS.

[351]  C. Fegan,et al.  Adenovirus infections following allogeneic stem cell transplantation: incidence and outcome in relation to graft manipulation, immunosuppression, and immune recovery. , 2002, Blood.

[352]  M. Maris,et al.  Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[353]  B. Herwaldt,et al.  Transmission of Babesia microti in Minnesota through four blood donations from the same donor over a 6‐month period , 2002, Transfusion.

[354]  D. Fong,et al.  Preemptive use of lamivudine reduces hepatitis B exacerbation after allogeneic hematopoietic cell transplantation , 2002, Hepatology.

[355]  A. Geyh,et al.  The Ability of Hospital Ventilation Systems to Filter Aspergillus and Other Fungi Following a Building Implosion , 2002, Infection Control & Hospital Epidemiology.

[356]  J Wagner,et al.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.

[357]  Theresa Hahn,et al.  Efficacy of High-Efficiency Particulate Air Filtration in Preventing Aspergillosis in Immunocompromised Patients With Hematologic Malignancies , 2002, Infection Control & Hospital Epidemiology.

[358]  T. Klimkait,et al.  Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. , 2002, The New England journal of medicine.

[359]  J. Fung,et al.  Cryptococcosis in Organ Transplant Recipients: An Overview , 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[360]  M. Yigla,et al.  Nosocomial outbreak of Legionella pneumophila serogroup 3 pneumonia in a new bone marrow transplant unit: evaluation, treatment and control , 2002, Bone Marrow Transplantation.

[361]  C. Donskey,et al.  Recurrence of Vancomycin-Resistant Enterococcus Stool Colonization During Antibiotic Therapy , 2002, Infection Control & Hospital Epidemiology.

[362]  D. Weisdorf,et al.  Penicillin-resistant Streptococcus pneumoniae septic shock and meningitis complicating chronic graft versus host disease: a case report and review of the literature. , 2002, The American journal of medicine.

[363]  A. Arvin,et al.  Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. , 2002, The New England journal of medicine.

[364]  David R. Holtgrave,et al.  Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. , 2002, Annals of internal medicine.

[365]  Meei-Li W Huang,et al.  Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale. , 2002, Blood.

[366]  Hans-Georg Rammensee,et al.  Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy. , 2002, Blood.

[367]  K. Yuen,et al.  Tuberculosis in blood and marrow transplant recipients , 2002, Hematological oncology.

[368]  Stéphane Hugonnet,et al.  Alcohol-based handrub improves compliance with hand hygiene in intensive care units. , 2002, Archives of internal medicine.

[369]  P. Ljungman,et al.  Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey , 2002, British journal of haematology.

[370]  P. Ljungman,et al.  Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants. , 2002, Blood.

[371]  D. Douek,et al.  Factors influencing T-lymphopoiesis after allogeneic hematopoietic cell transplantation1 , 2002, Transplantation.

[372]  S. Chevret,et al.  Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation. , 2002, Blood.

[373]  M. El-Masri,et al.  Performance of latex and nonlatex medical examination gloves during simulated use. , 2002, American journal of infection control.

[374]  Lawrence Corey,et al.  Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[375]  L. Pantanowitz,et al.  Tick‐borne diseases in transfusion medicine , 2002, Transfusion medicine.

[376]  Robert F Miller,et al.  Probable Mother-to-Infant Transmission of Pneumocystis carinii f. sp. hominis Infection , 2002, Journal of Clinical Microbiology.

[377]  Y. Wen,et al.  High hepatitis B virus (HBV) DNA viral load as the most important risk factor for HBV reactivation in patients positive for HBV surface antigen undergoing autologous hematopoietic cell transplantation. , 2002, Blood.

[378]  L. Pantanowitz,et al.  The impact of babesiosis on transfusion medicine. , 2002, Transfusion medicine reviews.

[379]  M. Maris,et al.  Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study. , 2002, Blood.

[380]  E. Anaissie,et al.  Pathogenic Aspergillus species recovered from a hospital water system: a 3-year prospective study. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[381]  H. Einsele,et al.  Randomized multicenter trial of foscarnet versus ganciclovir for preemptive therapy of cytomegalovirus infection after allogeneic stem cell transplantation. , 2002, Blood.

[382]  S. Lonial,et al.  Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation. , 2002, Blood.

[383]  J. Puck,et al.  Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survival. , 2002, Blood.

[384]  M. Boeckh,et al.  High risk of death due to bacterial and fungal infection among cytomegalovirus (CMV)-seronegative recipients of stem cell transplants from seropositive donors: evidence for indirect effects of primary CMV infection. , 2002, The Journal of infectious diseases.

[385]  L. Mammana,et al.  Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation , 2002, Bone Marrow Transplantation.

[386]  L. Corey,et al.  Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[387]  H. Kantarjian,et al.  Masking of Neutropenic Patients on Transport From Hospital Rooms Is Associated With a Decrease in Nosocomial Aspergillosis During Construction , 2002, Infection Control & Hospital Epidemiology.

[388]  Y. Kanda,et al.  Reverse Seroconversion of Hepatitis B Virus after Hematopoietic Stem Cell Transplantation , 2002, Leukemia & lymphoma.

[389]  A. Brand,et al.  Microbial contamination of cord blood stem cells , 2002, Vox sanguinis.

[390]  P. Ljungman,et al.  Leukocyte Depleted, Unscreened Blood Products Give a Low Risk for CMV Infection and Disease in CMV Seronegative Allogeneic Stem Cell Transplant Recipients with Seronegative Stem Cell Donors , 2002, Scandinavian journal of infectious diseases.

[391]  A. Nademanee,et al.  Autologous stem cell transplantation for HIV-associated lymphoma. , 2001, Blood.

[392]  E. Anaissie,et al.  Revisiting the source of candidemia: skin or gut? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[393]  C. Dykewicz.  Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: focus on community respiratory virus infections. , 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[394]  S. Chanock,et al.  Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[395]  G. Eliopoulos,et al.  Prolonged colonization with vancomycin-resistant Enterococcus faecium in long-term care patients and the significance of "clearance". , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[396]  R. Girones,et al.  Potential Transmission of Human Polyomaviruses through the Gastrointestinal Tract after Exposure to Virions or Viral DNA , 2001, Journal of Virology.

[397]  C. Dekker,et al.  Pediatric uses of valacyclovir, penciclovir and famciclovir. , 2001, The Pediatric infectious disease journal.

[398]  Edet E Udo,et al.  The spread of a mupirocin-resistant/methicillin-resistant Staphylococcus aureus clone in Kuwait hospitals. , 2001, Acta tropica.

[399]  K. K. Lai.  A cluster of invasive aspergillosis in a bone marrow transplant unit related to construction and the utility of air sampling. , 2001, American journal of infection control.

[400]  E. Carvalho,et al.  The value of an immunoenzymatic test (enzyme-linked immunosorbent assay) for the diagnosis of strongyloidiasis in patients immunosuppressed by hematologic malignancies. , 2001, The American journal of tropical medicine and hygiene.

[401]  M. Zambon,et al.  Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients , 2001, Bone Marrow Transplantation.

[402]  R. Ramphal,et al.  Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[403]  T. Ratko,et al.  Evidence‐based recommendations for the use of WBC‐reduced cellular blood components , 2001, Transfusion.

[404]  N. Russell,et al.  Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation , 2001, Bone Marrow Transplantation.

[405]  R. Martino,et al.  Quality control for the diagnosis of Toxoplasma gondii reactivation in SCT patients using PCR assays , 2001, Bone Marrow Transplantation.

[406]  B. van der Holt,et al.  Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT. , 2001, Blood.

[407]  M. Ryan,et al.  Handwashing and respiratory illness among young adults in military training. , 2001, American journal of preventive medicine.

[408]  D. Maloney,et al.  Factors influencing B lymphopoiesis after allogeneic hematopoietic cell transplantation. , 2001, Blood.

[409]  D. Pardi,et al.  Clostridium difficile-associated diarrhea and colitis. , 2001, Mayo Clinic proceedings.

[410]  M. Parise,et al.  Transfusion-transmitted malaria in the United States from 1963 through 1999. , 2001, The New England journal of medicine.

[411]  E. Daar,et al.  The Epidemiology of Invasive Pulmonary Aspergillosis at a Large Teaching Hospital , 2001, Infection Control & Hospital Epidemiology.

[412]  J. Wingard,et al.  Infections following hematopoietic stem cell transplantation. , 2001, Infectious disease clinics of North America.

[413]  R. Storb,et al.  Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. , 2001, Blood.

[414]  N. Ueno,et al.  Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation , 2001, Bone Marrow Transplantation.

[415]  J. Baddley,et al.  Invasive mold infections in allogeneic bone marrow transplant recipients. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[416]  G. Ehninger,et al.  SUCCESSFUL PREEMPTIVE CIDOFOVIR TREATMENT FOR CMV ANTIGENEMIA AFTER DOSE-REDUCED CONDITIONING AND ALLOGENEIC BLOOD STEM CELL TRANSPLANTATION , 2001, Transplantation.

[417]  S. Holland,et al.  Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. , 2001, The New England journal of medicine.

[418]  L. Elting,et al.  Adenovirus infections in adult recipients of blood and marrow transplants. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[419]  C. Craddock,et al.  Direct visualization of cytomegalovirus-specific T-cell reconstitution after allogeneic stem cell transplantation. , 2001, Blood.

[420]  C. Flowers,et al.  Nonmyeloablative Hematopoietic Cell Transplantation , 2001, Current opinion in oncology.

[421]  M. Boeckh,et al.  Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. , 2001, Blood.

[422]  P. Thall,et al.  Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation. , 2001, Blood.

[423]  H. Einsele,et al.  Cidofovir for cytomegalovirus infection and disease in allogeneic stem cell transplant recipients. The Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. , 2001, Blood.

[424]  E. Rocha,et al.  [Treatment of visceral leishmaniasis with liposomal amphotericin B in three immunocompromised patients]. , 2001, Medicina clinica.

[425]  E. Rocha,et al.  Tratamiento con anfotericina B liposomal en tres pacientes inmunodeprimidos con leishmaniasis visceral , 2001 .

[426]  A. Streifel,et al.  An Evaluation of Hospital Special-Ventilation-Room Pressures , 2001, Infection Control & Hospital Epidemiology.

[427]  G. Tsongalis,et al.  Kaposi’s Sarcoma following Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Myelogenous Leukemia , 2001, Acta Haematologica.

[428]  L. Rice,et al.  Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. , 2000, The New England journal of medicine.

[429]  R. Tedder,et al.  Extended routine polymerase chain reaction surveillance and pre‐emptive antiviral therapy for cytomegalovirus after allogeneic transplantation , 2000, British journal of haematology.

[430]  G. Davison,et al.  Immune reconstitution following hematopoietic stem-cell transplantation. , 2001, Cytotherapy.

[431]  D. Maloney,et al.  Transplantation Infection Rates between Days 100 and 365 after Allogeneic Marrow Low B-cell and Monocyte Counts on Day 80 Are Associated with High , 2022 .

[432]  P. Mahendra,et al.  Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma , 2000, Bone Marrow Transplantation.

[433]  T. Klingebiel,et al.  Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes. , 2000, Blood.

[434]  J. Armitage,et al.  2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[435]  D. Heilman,et al.  Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. , 2000, Blood.

[436]  S. Hugonnet,et al.  Effectiveness of a hospital-wide programme to improve compliance with hand hygiene , 2000, The Lancet.

[437]  K. Sepkowitz,et al.  Rotavirus outbreak on a pediatric oncology floor: possible association with toys. , 2000, American journal of infection control.

[438]  T. Leet,et al.  Environmental control to reduce transmission of Clostridium difficile. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[439]  P. Moreau,et al.  Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: a single-center prospective longitudinal study of 92 patients. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[440]  Marrow Transplantation.  Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients , 2000, Biology of Blood and Marrow Transplantation.

[441]  C. Siegrist,et al.  Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. , 2000, Blood.

[442]  M. Boeckh,et al.  Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial. , 2000, Blood.

[443]  C. Cordonnier,et al.  Prospective study of toxoplasma reactivation by polymerase chain reaction in allogeneic stem‐cell transplant recipients , 2000, Transplant infectious disease : an official journal of the Transplantation Society.

[444]  J. Duchin,et al.  Legionnaires' disease associated with potting soil--California, Oregon, and Washington, May-June 2000. , 2000, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[445]  A. Nademanee,et al.  High dose therapy and autologous stem cell transplantation for human immunodeficiency virus‐associated non‐Hodgkin lymphoma in the era of highly active antiretroviral therapy , 2000, Cancer.

[446]  J. Sierra,et al.  Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome , 2000, Bone Marrow Transplantation.

[447]  S. Sattar,et al.  Activity of an Alcohol-Based Hand Gel Against Human Adeno-, Rhino-, and Rotaviruses Using the Fingerpad Method , 2000, Infection Control & Hospital Epidemiology.

[448]  G A Noskin,et al.  Persistent contamination of fabric-covered furniture by vancomycin-resistant enterococci: implications for upholstery selection in hospitals. , 2000, American journal of infection control.

[449]  M. Davies,et al.  Bacterial Colonization of Toys in Neonatal Intensive Care Cots , 2000, Pediatrics.

[450]  J. Vinjé,et al.  Infectious gastro-enteritis: an uncommon cause of diarrhoea in adult allogeneic and autologous stem cell transplant recipients , 2000, Bone Marrow Transplantation.

[451]  A. Widmer.  Replace hand washing with use of a waterless alcohol hand rub? , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[452]  Q. Sun,et al.  A phase I-II trial to examine the toxicity of CMV- and EBV-specific cytotoxic T lymphocytes when used for prophylaxis against EBV and CMV disease in recipients of CD34-selected/T cell-depleted stem cell transplants. , 2000 .

[453]  Z. Başlar,et al.  The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[454]  H. Jansens,et al.  A prospective study on factors influencing aspergillus spore load in the air during renovation works in a neonatal intensive care unit. , 2000, The Journal of hospital infection.

[455]  Prevots Dr,et al.  Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000 .

[456]  T. Small,et al.  Disseminated toxoplasmosis following T cell-depleted related and unrelated bone marrow transplantation , 2000, Bone Marrow Transplantation.

[457]  B. Robinson-Dunn,et al.  Salmonellosis associated with chicks and ducklings--Michigan and Missouri, Spring 1999. , 2000, MMWR. Morbidity and mortality weekly report.

[458]  R. Wenzel,et al.  Handwashing compliance by health care workers: The impact of introducing an accessible, alcohol-based hand antiseptic. , 2000, Archives of internal medicine.

[459]  S. Singhal,et al.  Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial , 2000, The Lancet.

[460]  Sergio L Vargas,et al.  Transmission of Pneumocystis carinii DNA from a Patient with P. carinii Pneumonia to Immunocompetent Contact Health Care Workers , 2000, Journal of Clinical Microbiology.

[461]  Louisa Jorm,et al.  Effect of Infection Control Measures on the Frequency of Upper Respiratory Infection in Child Care: A Randomized, Controlled Trial , 2000, Pediatrics.

[462]  V. Dietz,et al.  Preventing congenital toxoplasmosis. , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[463]  C. Katlama,et al.  High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma , 2000, The Lancet.

[464]  C. Knirsch,et al.  An outbreak of Legionella micdadei pneumonia in transplant patients: evaluation, molecular epidemiology, and control. , 2000, The American journal of medicine.

[465]  M. Richardson,et al.  Sampling of Aspergillus spores in air. , 2000, The Journal of hospital infection.

[466]  I. Ernberg,et al.  Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: prophylactic infusion of EBV-specific cytotoxic T cells. , 2000, Blood.

[467]  L. Hutwagner,et al.  A Prolonged Outbreak of Pseudomonas Aeruginosa in a Neonatal Intensive Care Unit Did Staff Fingernails Play a Role in Disease Transmission? , 2000, Infection Control & Hospital Epidemiology.

[468]  P. Fast,et al.  Genotypic Stability of Cold-Adapted Influenza Virus Vaccine in an Efficacy Clinical Trial , 2000, Journal of Clinical Microbiology.

[469]  P. Ljungman,et al.  Granulocyte-macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[470]  K. Kain,et al.  Transfusion-transmitted babesiosis in Ontario: first reported case in Canada. , 2000, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[471]  A. Streifel,et al.  Refinements of Environmental Assessment During an Outbreak Investigation of Invasive Aspergillosis in a Leukemia and Bone Marrow Transplant Unit , 2000, Infection Control & Hospital Epidemiology.

[472]  S. Crawford,et al.  High rates of Pneumocystis carinii pneumonia in allogeneic blood and marrow transplant recipients receiving dapsone prophylaxis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[473]  M Pittard,et al.  Adenovirus infections in hematopoietic stem cell transplant recipients. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[474]  D. Pillay,et al.  Prevalence of long‐term BK and JC excretion in HIV‐infected adults and lack of correlation with serological markers , 1999, Journal of medical virology.

[475]  N. Cox.  Prevention and control of influenza , 1999, The Lancet.

[476]  T. Perl,et al.  An outbreak of vancomycin-dependent Enterococcus faecium in a bone marrow transplant unit. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[477]  D. Leiby,et al.  Prospective evaluation of a patient with Trypanosoma cruzi infection transmitted by transfusion. , 1999, The New England journal of medicine.

[478]  W. Hryniewicz,et al.  Outbreak of Mupirocin-Resistant Staphylococci in a Hospital in Warsaw, Poland, Due to Plasmid Transmission and Clonal Spread of Several Strains , 1999, Journal of Clinical Microbiology.

[479]  M. Aljurf,et al.  Mycobacterium tuberculosis infection in allogeneic bone marrow transplantation patients , 1999, Bone Marrow Transplantation.

[480]  J. Montaner,et al.  Atovaquone suspension compared with aerosolized pentamidine for prevention of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected subjects intolerant of trimethoprim or sulfonamides. , 1999, The Journal of infectious diseases.

[481]  A. Monto,et al.  Zanamivir in the prevention of influenza among healthy adults: a randomized controlled trial. , 1999, JAMA.

[482]  R. Zittoun,et al.  Efficacy of Prevention by High-Efficiency Particulate Air Filtration or Laminar Airflow Against Aspergillus Airborne Contamination During Hospital Renovation , 1999, Infection Control & Hospital Epidemiology.

[483]  C. Demur,et al.  Plasmodium falciparum infection following allogeneic bone-marrow transplantation. , 1999, Annals of tropical medicine and parasitology.

[484]  K. Sullivan,et al.  Hepatitis C virus infection and bone marrow transplantation: A cohort study with 10‐year follow‐up , 1999, Hepatology.

[485]  L. Feldman,et al.  Reactivation of chronic Chagas’ disease following allogeneic bone marrow transplantation and successful pre‐emptive therapy with benznidazole , 1999, Transplant infectious disease : an official journal of the Transplantation Society.

[486]  Stephan Harbarth,et al.  Randomized, Placebo-Controlled, Double-Blind Trial To Evaluate the Efficacy of Mupirocin for Eradicating Carriage of Methicillin-Resistant Staphylococcus aureus , 1999, Antimicrobial Agents and Chemotherapy.

[487]  M. Giambiagi-deMarval,et al.  Molecular Characterization and Transfer Among Staphylococcus Strains of a Plasmid Conferring High-Level Resistance to Mupirocin , 1999, European Journal of Clinical Microbiology and Infectious Diseases.

[488]  A. Elmaagacli,et al.  Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospect , 1999, Blood.

[489]  R. Holman,et al.  Reye's syndrome in the United States from 1981 through 1997. , 1999, The New England journal of medicine.

[490]  Teresa C. Horan,et al.  Guideline for Prevention of Surgical Site Infection, 1999 , 1999, Infection Control & Hospital Epidemiology.

[491]  D. Leiby,et al.  Trypanosoma cruzi in a low‐ to moderate‐risk blood donor population: seroprevalence and possible congenital transmission , 1999, Transfusion.

[492]  R. Folz,et al.  Coronavirus Pneumonia Following Autologous Bone Marrow Transplantation for Breast Cancer , 1999, Chest.

[493]  F. Waldvogel.  New resistance in Staphylococcus aureus. , 1999, The New England journal of medicine.

[494]  B. Robinson-Dunn,et al.  Emergence of Vancomycin Resistance inStaphylococcus aureus , 1999 .

[495]  M. Pham,et al.  Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. , 1999, The Journal of infectious diseases.

[496]  W. Rutala,et al.  Disinfection of Endoscopes: Review of New Chemical Sterilants Used for High-Level Disinfection , 1999, Infection Control & Hospital Epidemiology.

[497]  Joseph C. Carpenter,et al.  More than 10 Years of Unrecognized Nosocomial Transmission of Legionnaires' Disease Among Transplant Patients , 1998, Infection Control & Hospital Epidemiology.

[498]  R. V. van Lier,et al.  Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. , 1998, Blood.

[499]  J. Robson,et al.  Saksenaea vasiformis breast abscess related to gardening injury. , 1998, Australian and New Zealand journal of medicine.

[500]  Cavazzana‐Calvo,et al.  Prevention of EBV‐induced B‐lymphoproliferative disorder by ex vivo marrow B‐cell depletion in HLA‐phenoidentical or non‐identical T‐depleted bone marrow transplantation , 1998, British journal of haematology.

[501]  M. Villarino.  Prevention and treatment of tuberculosis among patients infected with human immunodeficiency virus; principles of therapy and revised recommendations , 1998 .

[502]  M. Martelli,et al.  Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. , 1998, The New England journal of medicine.

[503]  K. Yuen,et al.  Risk factors for pulmonary tuberculosis in bone marrow transplant recipients. , 1998, American journal of respiratory and critical care medicine.

[504]  J. Verhoef,et al.  The prevalence of low- and high-level mupirocin resistance in staphylococci from 19 European hospitals. , 1998, The Journal of antimicrobial chemotherapy.

[505]  M. Boeckh,et al.  Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications , 1998, Clinical Microbiology Reviews.

[506]  T. Lamparelli,et al.  Foscarnet vs ganciclovir for cytomegalovirus (CMV) antigenemia after allogeneic hemopoietic stem cell transplantation (HSCT): a randomised study , 1998, Bone Marrow Transplantation.

[507]  S. Tabrizi,et al.  Multiresistant Pseudomonas aeruginosa outbreak in a pediatric oncology ward related to bath toys. , 1998, The Pediatric infectious disease journal.

[508]  S. Deitchman,et al.  Guideline for Infection Control in Healthcare Personnel, 1998 , 1998, Infection Control & Hospital Epidemiology.

[509]  A. Gratwohl,et al.  Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia , 1998, Bone Marrow Transplantation.

[510]  B. Stover,et al.  Varicella-zoster virus: infection, control, and prevention. , 1998, American journal of infection control.

[511]  R. Dodd.  Transmission of Parasites by Blood Transfusion , 1998, Vox sanguinis.

[512]  S. Deitchman,et al.  Guideline for Infection Control in Healthcare Personnel, 1998 , 1998, Infection Control & Hospital Epidemiology.

[513]  K. Cornetta,et al.  Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV-induced lymphoproliferative disease after stem cell transplantation. , 1998, Blood.

[514]  D. Gerding,et al.  Clostridium difficile--associated diarrhea. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[515]  B. Cookson,et al.  Control of an outbreak of an epidemic methicillin-resistant Staphylococcus aureus also resistant to mupirocin. , 1998, The Journal of hospital infection.

[516]  J. Lau,et al.  Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[517]  C. Sabin,et al.  Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease , 1998, Bone Marrow Transplantation.

[518]  E. Segura,et al.  Recipients and donors of bone marrow transplants suffering from Chagas’ disease: management and preemptive therapy of parasitemia , 1998, Bone Marrow Transplantation.

[519]  C. Richard,et al.  Pneumococcal pericarditis with cardiac tamponade in a patient with chronic graft-versus-host disease , 1998, Bone Marrow Transplantation.

[520]  I. Roberts,et al.  Donor-derived Plasmodium vivax infection following volunteer unrelated bone marrow transplantation , 1998, Bone Marrow Transplantation.

[521]  R. Adams,et al.  Animals in schools: a zoonosis threat? , 1998, The Pediatric infectious disease journal.

[522]  J. Ariza,et al.  Epidemiology and Successful Control of a Large Outbreak Due to Klebsiella pneumoniae Producing ExtendedSpectrum β-Lactamases , 1998, Antimicrobial Agents and Chemotherapy.

[523]  D. Petropoulos,et al.  Dapsone for Pneumocystis carinii prophylaxis in children undergoing bone marrow transplantation , 1997, Bone Marrow Transplantation.

[524]  J. L. Goodman,et al.  Primary bone marrow progenitors of both granulocytic and monocytic lineages are susceptible to infection with the agent of human granulocytic ehrlichiosis. , 1997, The Journal of infectious diseases.

[525]  E. Read,et al.  Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors. , 1997, The Journal of infectious diseases.

[526]  Centersfordiseasecontrolandpr.  Interim guidelines for prevention and control of Staphylococcal infection associated with reduced susceptibility to vancomycin. , 1997, MMWR. Morbidity and mortality weekly report.

[527]  D. Fleming,et al.  A prolonged outbreak of Escherichia coli O157:H7 infections caused by commercially distributed raw milk. , 1997, The Journal of infectious diseases.

[528]  J. Niland,et al.  Late cytomegalovirus disease in marrow transplantation is predicted by virus load in plasma. , 1997, The Journal of infectious diseases.

[529]  Andreas Radbruch,et al.  Lifetime of plasma cells in the bone marrow , 1997, Nature.

[530]  A. Buzaid,et al.  Minocycline and ethylenediaminetetraacetate for the prevention of recurrent vascular catheter infections. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[531]  Stiehm Er.  Human intravenous immunoglobulin in primary and secondary antibody deficiencies. , 1997 .

[532]  R. Hackman,et al.  Nocardiosis after bone marrow transplantation: a retrospective study. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[533]  J. Englund,et al.  Nosocomial Respiratory Syncytial Virus Infections Prevention and Control in Bone Marrow Transplant Patients , 1997, Infection Control & Hospital Epidemiology.

[534]  H. Einsele,et al.  Screening for CMV-specific T cell proliferation to identify patients at risk of developing late onset CMV disease , 1997, Bone Marrow Transplantation.

[535]  M. Saag.  Candidate antiretroviral agents for use in postexposure prophylaxis. , 1997, The American journal of medicine.

[536]  D. Dimitrov,et al.  Distinctions between CD8+ and CD4+ T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. , 1997, Blood.

[537]  P. Ljungman,et al.  Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections , 1997, Bone Marrow Transplantation.

[538]  L. Chiarello,et al.  Management of Healthcare Workers Infected With Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, or Other Bloodborne Pathogens , 1997, Infection Control & Hospital Epidemiology.

[539]  F. Momin,et al.  Disseminated toxoplasmosis in marrow recipients: a report of three cases and a review of the literature , 1997, Bone Marrow Transplantation.

[540]  I. Raad,et al.  Infection control of nosocomial respiratory viral disease in the immunocompromised host. , 1997, The American journal of medicine.

[541]  F. Hayden.  Prevention and treatment of influenza in immunocompromised patients. , 1997, The American journal of medicine.

[542]  MD Estella Whimbey,et al.  Community Respiratory Virus Infections in Immunocompromised Patients with Cancer , 1997, The American Journal of Medicine.

[543]  J. Englund,et al.  Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. , 1997, The American journal of medicine.

[544]  B. Hoar,et al.  Iguanas and Salmonella marina infection in children: a reflection of the increasing incidence of reptile-associated salmonellosis in the United States. , 1997, Pediatrics.

[545]  P. Moreau,et al.  Prospective randomized placebo-controlled study of granulocyte-macrophage colony-stimulating factor without stem-cell transplantation after high-dose melphalan in patients with multiple myeloma. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[546]  K. Sullivan,et al.  Infectious morbidity in long‐term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts , 1997, American journal of hematology.

[547]  L. Brammer,et al.  Influenza surveillance--United States, 1992-93 and 1993-94. , 1997, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[548]  J. Ritz,et al.  Prevention of transmission of hepatitis C virus in bone marrow transplantation by treating the donor with alpha-interferon. , 1996, Transplantation.

[549]  M. Boeckh,et al.  Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. , 1996, Blood.

[550]  T. Stevens-Ayers,et al.  Cytomegalovirus pp65 antigenemia after autologous marrow and peripheral blood stem cell transplantation. , 1996, The Journal of infectious diseases.

[551]  A. Messori,et al.  Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[552]  H. Deeg,et al.  Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. , 1996, Bone marrow transplantation.

[553]  C. Stratton,et al.  Lactobacillus bacteremia: description of the clinical course in adult patients without endocarditis. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[554]  H. Lazarus,et al.  Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation , 1996, Transfusion.

[555]  J. Lieberman,et al.  EBV-specific cytotoxic T lymphocytes protect against human EBV-associated lymphoma in scid mice. , 1996, Immunology letters.

[556]  M. Hocking,et al.  Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors , 1996, The Lancet.

[557]  J. Hermans,et al.  Risk factors for developing EBV-related B cell lymphoproliferative disorders (BLPD) after non-HLA-identical BMT in children. , 1996, Bone marrow transplantation.

[558]  J. Binet,et al.  Transmission of Plasmodium falciparum by allogeneic bone marrow transplantation. , 1996, Bone marrow transplantation.

[559]  Rutala Wa,et al.  APIC guideline for selection and use of disinfectants. 1994, 1995, and 1996 APIC Guidelines Committee. Association for Professionals in Infection Control and Epidemiology, Inc. , 1996 .

[560]  W A Rutala,et al.  APIC guideline for selection and use of disinfectants. , 1996, American journal of infection control.

[561]  G. Wormser,et al.  Bloodstream infections with vancomycin-resistant enterococci. , 1996, Archives of internal medicine.

[562]  H. Moraes-Souza,et al.  Strategies for prevention of transfusion-associated Chagas' disease. , 1996, Transfusion medicine reviews.

[563]  P. Ruutu,et al.  Late onset Pneumocystis carinii pneumonia following allogeneic bone marrow transplantation. , 1996, Bone marrow transplantation.

[564]  R. Soiffer,et al.  Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation. , 1996, Bone marrow transplantation.

[565]  V. Loo,et al.  Control of Construction-Associated Nosocomial Aspergillosis in an Antiquated Hematology Unit , 1996, Infection Control & Hospital Epidemiology.

[566]  T. Sata,et al.  Clinical features of measles in immunocompromised children , 1996, Acta paediatrica Japonica : Overseas edition.

[567]  R. Couch,et al.  Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[568]  R. Huebner,et al.  The Role of BCG Vaccine in the prevention and control of tuberculosis in the United States; a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices , 1996 .

[569]  T. Lundstrom,et al.  Controlling Vancomycin-Resistant Enterococci , 1996, Infection Control & Hospital Epidemiology.

[570]  M. Boeckh,et al.  Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[571]  E. Bryce,et al.  An Outbreak of Cutaneous Aspergillosis in a Tertiary-Care Hospital , 1996, Infection Control & Hospital Epidemiology.

[572]  H. Deeg,et al.  A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery. , 1996, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[573]  G. Wormser,et al.  Natural History of Colonization with Vancomycin-Resistant Enterococcus Faecium , 1995, Infection Control & Hospital Epidemiology.

[574]  Hayden Fg,et al.  Orthomyxoviral and paramyxoviral infections in transplant patients. , 1995 .

[575]  J. Wagner,et al.  Late infections after allogeneic bone marrow transplantations: comparison of incidence in related and unrelated donor transplant recipients. , 1995, Blood.

[576]  C. Golledge.  An infection from a penetrating plant wound. , 1995, Australian family physician.

[577]  K. Weinberg,et al.  The effect of thymic function on immunocompetence following bone marrow transplantation. , 1995, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[578]  M. Thomson,et al.  A comparison of the efficacy of insecticide-treated and untreated bed nets in preventing malaria in Gambian children. , 1995, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[579]  G. Schoch,et al.  A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant. , 1995, Blood.

[580]  S. Riddell,et al.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. , 1995, The New England journal of medicine.

[581]  M. Boeckh,et al.  Failure of high-dose acyclovir to prevent cytomegalovirus disease after autologous marrow transplantation. , 1995, The Journal of infectious diseases.

[582]  F. Alcaide,et al.  In vitro activities of 22 beta-lactam antibiotics against penicillin-resistant and penicillin-susceptible viridans group streptococci isolated from blood , 1995, Antimicrobial agents and chemotherapy.

[583]  K. Holmes,et al.  USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: introduction. USPHS/IDSA Prevention of Opportunistic Infections Working Group. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[584]  D. Hurd,et al.  Reactivation toxoplasmic retinochoroiditis in patients undergoing bone marrow transplantation: is there a role for chemoprophylaxis? , 1995, Bone marrow transplantation.

[585]  M. Levenstein,et al.  Efficacy and safety of fluconazole prophylaxis for fungal infections after marrow transplantation--a prospective, randomized, double-blind study. , 1995, The Journal of infectious diseases.

[586]  L. Koonin,et al.  Abortion surveillance--United States, 1991. , 1995, MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries.

[587]  S. Goodman,et al.  Association of BK virus with failure of prophylaxis against hemorrhagic cystitis following bone marrow transplantation. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[588]  R. Truitt,et al.  Characterization of human proliferative T cell responses to adenovirus. , 1995, The Journal of infectious diseases.

[589]  A. Alberti,et al.  Hepatitis C virus serum markers and liver disease in children with leukemia. , 1995, Leukemia & lymphoma.

[590]  C. Dalton,et al.  Iguana-associated salmonellosis in children. , 1995, The Pediatric infectious disease journal.

[591]  J. Armitage,et al.  Clinical applications of hematopoietic growth factors. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[592]  R. Hoffman,et al.  Hematology: Basic Principles and Practice , 1995 .

[593]  H. Einsele,et al.  Immunisations after bone marrow transplantation: results of a European survey and recommendations from the infectious diseases working party of the European Group for Blood and Marrow Transplantation. , 1995, Bone marrow transplantation.

[594]  S. Steinberg,et al.  Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. , 1995, The New England journal of medicine.

[595]  C. Glaser,et al.  Caring for pets of immunocompromised persons. , 1994, Journal of the American Veterinary Medical Association.

[596]  B. Childs,et al.  Marrow transplantation from hepatitis C virus seropositive donors: transmission rate and clinical course. , 1994, Blood.

[597]  J. Meyers,et al.  Hepatosplenic candidiasis--a contraindication to marrow transplantation? , 1994, Blood.

[598]  F. Derouin,et al.  Prophylaxis of toxoplasmosis infection with pyrimethamine/sulfadoxine (Fansidar) in bone marrow transplant recipients. , 1994, Bone marrow transplantation.

[599]  G. Peter.  Summary of Major Changes in the 1994 Red Book: Report of the Committee on Infectious Diseases , 1994, Pediatrics.

[600]  R. Hackman,et al.  Toxoplasma gondii infection in marrow transplant recipients: a 20 year experience. , 1994, Bone marrow transplantation.

[601]  M. Ladanyi,et al.  Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. , 1994, The New England journal of medicine.

[602]  S. Gerson,et al.  Aspergillosis due to carpet contamination. , 1994, Infection control and hospital epidemiology.

[603]  G. Bodey,et al.  Prevention of Central Venous Catheter-Related Infections by Using Maximal Sterile Barrier Precautions During Insertion , 1994, Infection Control & Hospital Epidemiology.

[604]  M. Horowitz,et al.  Increasing incidence of adenovirus disease in bone marrow transplant recipients. , 1994, The Journal of infectious diseases.

[605]  P. Ljungman,et al.  Immunity to poliovirus and immunization with inactivated poliovirus vaccine after autologous bone marrow transplantation. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[606]  F. Mandelli,et al.  Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation , 1994, The Lancet.

[607]  S. Sallan,et al.  Polysaccharide conjugate vaccine responses in bone marrow transplant patients. , 1994, Transplantation.

[608]  C. Sable,et al.  Infections in bone marrow transplant recipients. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[609]  Report of the Committee on Infectious Diseases , 1994 .

[610]  T. Yoshikawa,et al.  Seroepidemiology of human herpesvirus 7 in healthy children and adults in Japan , 1993, Journal of medical virology.

[611]  E. Romanowski,et al.  Prolonged recovery of desiccated adenoviral serotypes 5, 8, and 19 from plastic and metal surfaces in vitro. , 1993, Ophthalmology.

[612]  J. Roberts,et al.  Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency. , 1993, Seminars in hematology.

[613]  P. Weller,et al.  Strongyloidiasis and other intestinal nematode infections. , 1993, Infectious disease clinics of North America.

[614]  R. Yolken,et al.  Prevalence of rotavirus on high-risk fomites in day-care facilities. , 1993, Pediatrics.

[615]  R. Collins,et al.  High-Dose Weekly Intravenous Immunoglobulin to Prevent Infections in Patients Undergoing Autologous Bone Marrow Transplantation or Severe Myelosuppressive Therapy: A Study of the American Bone Marrow Transplant Group , 1993, Annals of Internal Medicine.

[616]  G. Ehninger,et al.  Pentamidine aerosol for prophylaxis of Pneumocystis carinii pneumonia after BMT. , 1993, Bone marrow transplantation.

[617]  L. Corey,et al.  Human herpesvirus 6 DNA in peripheral blood cells and saliva from immunocompetent individuals , 1993, Journal of clinical microbiology.

[618]  J. Villablanca,et al.  Viridans streptococcal shock in bone marrow transplantation patients , 1993, American journal of hematology.

[619]  D. Conway,et al.  Immunodiagnosis of Strongyloides stercoralis infection: a method for increasing the specificity of the indirect ELISA. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[620]  G. Schoch,et al.  Ganciclovir Prophylaxis To Prevent Cytomegalovirus Disease after Allogeneic Marrow Transplant , 1993, Annals of Internal Medicine.

[621]  R. Champlin,et al.  Ganciclovir Prophylaxis of Cytomegalovirus Infection and Disease in Allogeneic Bone Marrow Transplant Recipients: Results of a Placebo-Controlled, Double-Blind Trial , 1993, Annals of Internal Medicine.

[622]  G. Gahrton,et al.  Cytomegalovirus viraemia and specific T‐helper cell responses as predictors of disease after allogeneic marrow transplantation , 1993, British journal of haematology.

[623]  C. Cordonnier,et al.  Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. , 1992, The Journal of infectious diseases.

[624]  P. Madge,et al.  Prospective controlled study of four infection-control procedures to prevent nosocomial infection with respiratory syncytial virus , 1992, The Lancet.

[625]  D. Weisdorf,et al.  Pneumocystis carinii pneumonitis following bone marrow transplantation. , 1992, Bone marrow transplantation.

[626]  L. Peterson,et al.  Treatment of Asymptomatic Clostridium difficile Carriers (Fecal Excretors) with Vancomycin or Metronidazole , 1992, Annals of Internal Medicine.

[627]  F. Derouin,et al.  Toxoplasmosis in bone marrow-transplant recipients: report of seven cases and review. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[628]  P. Ljungman,et al.  Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. , 1992, Bone marrow transplantation.

[629]  B. Osborne,et al.  An outbreak of respiratory syncytial virus in a bone marrow transplant center. , 1992, The Journal of infectious diseases.

[630]  J. L. Goodman,et al.  A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation. , 1992, The New England journal of medicine.

[631]  J. Meyers,et al.  Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. , 1991, The New England journal of medicine.

[632]  P. Francioli,et al.  Transmission of Pneumocystis carinii from AIDS patients to other immunosuppressed patients: a cluster of Pneumocystis carinii pneumonia in renal transplant recipients. , 1991, AIDS.

[633]  R. Buckley,et al.  The use of intravenous immune globulin in immunodeficiency diseases. , 1991, The New England journal of medicine.

[634]  T. Berger,et al.  Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection. , 1991, Annals of internal medicine.

[635]  J. Meyers,et al.  Infection Complicating Bone Marrow Transplantation , 1991 .

[636]  J. Niland,et al.  A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants , 1991 .

[637]  M. Amylon,et al.  Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings. , 1991, Pediatrics.

[638]  E. Romanowski,et al.  Prolonged recoverability of desiccated adenovirus type 19 from various surfaces. , 1990, Ophthalmology.

[639]  M. Gale,et al.  Possible transfer of Pneumocystis carinii between kidney transplant recipients , 1990, The Lancet.

[640]  G. Heller,et al.  B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny. , 1990, Blood.

[641]  H. Albrecht,et al.  Possible transfer of Pneumocystis carinii between immunodeficient patients , 1990, The Lancet.

[642]  T. Albrecht,et al.  Human cytomegalovirus , 1990, Archives of Virology.

[643]  M. Pepe,et al.  Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. , 1990, The Journal of infectious diseases.

[644]  J. Lew,et al.  Viral agents of gastroenteritis. Public health importance and outbreak management. , 1990, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[645]  A. Bosi,et al.  Kinetics of anti-CMV antibodies after administration of intravenous immunoglobulins to bone marrow transplant recipients. , 1990, Haematologica.

[646]  L. Peterson,et al.  Prospective, controlled study of vinyl glove use to interrupt Clostridium difficile nosocomial transmission. , 1990, The American journal of medicine.

[647]  K. Rand,et al.  Pharmacokinetics of cytomegalovirus specific IgG antibody following intravenous immunoglobulin in bone marrow transplant patients. , 1989, Bone marrow transplantation.

[648]  P. Bitterman,et al.  Respiratory Syncytial Virus‐Induced Acute Lung Injury in Adult Patients with Bone Marrow Transplants: A Clinical Approach and Review of the Literature , 1989, Medicine.

[649]  T. Rogers,et al.  Control of an outbreak of nosocomial aspergillosis by laminar air-flow isolation. , 1989, The Journal of hospital infection.

[650]  Henry Nider,et al.  Report of the Committee on Infectious Diseases , 1989 .

[651]  T. J. Walsh,et al.  Nosocomial aspergillosis: Environmental microbiology, hospital epidemiology, diagnosis and treatment , 1989, European Journal of Epidemiology.

[652]  G. Gahrton,et al.  Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. , 1989, The Journal of infectious diseases.

[653]  D. Nalin,et al.  Ivermectin for human strongyloidiasis and other intestinal helminths. , 1989, The American journal of tropical medicine and hygiene.

[654]  D A Rasley,et al.  Surveillance of nosocomial infections , 1989, Critical care nursing quarterly.

[655]  W. Stamm,et al.  Nosocomial acquisition of Clostridium difficile infection. , 1989, The New England journal of medicine.

[656]  L. Poellinger,et al.  The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. , 1988, Virology.

[657]  J. Sinnott,et al.  Respiratory Syncytial Virus , 1988, Infection Control & Hospital Epidemiology.

[658]  K. Shah,et al.  BK and JC virus infections in recipients of bone marrow transplants. , 1988, The Journal of infectious diseases.

[659]  M. Zutter,et al.  Epstein-Barr virus lymphoproliferation after bone marrow transplantation. , 1988, Blood.

[660]  G. Wells,et al.  Rotavirus survival on human hands and transfer of infectious virus to animate and nonporous inanimate surfaces , 1988, Journal of clinical microbiology.

[661]  A. Josephson,et al.  Airborne transmission of nosocomial varicella from localized zoster. , 1988, The Journal of infectious diseases.

[662]  M. Pfaller,et al.  RESPIRATORY SYNCYTIAL VIRUS INFECTIONS IN ADULT BONE MARROW TRANSPLANT RECIPIENTS , 1988, The Lancet.

[663]  K. Yamanishi,et al.  IDENTIFICATION OF HUMAN HERPESVIRUS-6 AS A CAUSAL AGENT FOR EXANTHEM SUBITUM , 1988, The Lancet.

[664]  B. Burke,et al.  Epstein-Barr virus associated B cell lymphoproliferative disorders following bone marrow transplantation. , 1988, Blood.

[665]  W. Martone,et al.  Construction Activity: An Independent Risk Factor for Invasive Aspergillosis and Zygomycosis in Patients with Hematologic Malignancy , 1987, Infection Control.

[666]  C. Hutto,et al.  Isolation of cytomegalovirus from toys and hands in a day care center. , 1986, The Journal of infectious diseases.

[667]  K. Shah,et al.  Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants. , 1986, The New England journal of medicine.

[668]  C B Hall,et al.  Respiratory syncytial viral infection in children with compromised immune function. , 1986, The New England journal of medicine.

[669]  R. Jones,et al.  Outbreak of primary cutaneous aspergillosis related to intravenous arm boards. , 1986, The Journal of pediatrics.

[670]  S. Sattar,et al.  Institutional outbreaks of rotavirus diarrhoea: potential role of fomites and environmental surfaces as vehicles for virus transmission , 1986, Journal of Hygiene.

[671]  R. Burk,et al.  Hepatitis B virus DNA contains a glucocorticoid-responsive element. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[672]  S. Opal,et al.  Efficacy of infection control measures during a nosocomial outbreak of disseminated aspergillosis associated with hospital construction. , 1986, The Journal of infectious diseases.

[673]  A. Burks,et al.  Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA. , 1986, The New England journal of medicine.

[674]  R. Locksley,et al.  Infection with varicella-zoster virus after marrow transplantation. , 1985, The Journal of infectious diseases.

[675]  L. Goldberg,et al.  Pet-associated illness. , 1985, The New England journal of medicine.

[676]  A. Shields,et al.  Adenovirus infections in patients undergoing bone-marrow transplantation. , 1985, The New England journal of medicine.

[677]  F. Staib.  Ecological and epidemiological aspects of aspergilli pathogenic for man and animal in Berlin (West). , 1984, Zentralblatt fur Bakteriologie, Mikrobiologie, und Hygiene. Series A, Medical microbiology, infectious diseases, virology, parasitology.

[678]  N. Flournoy,et al.  Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation. , 1984, Annals of internal medicine.

[679]  A. Streifel,et al.  Extrinsic risk factors for pneumonia in the patient at high risk of infection. , 1984, The American journal of medicine.

[680]  R. Summers,et al.  Desensitization for sulfasalazine skin rash. , 1984, Annals of internal medicine.

[681]  C. Kaiser,et al.  Laboratory diagnosis of viral infections. , 1983, American family physician.

[682]  E. Gluckman,et al.  PROPHYLAXIS OF HERPES INFECTIONS AFTER BONE-MARROW TRANSPLANTATION BY ORAL ACYCLOVIR , 1983, The Lancet.

[683]  K. Sullivan,et al.  Analysis of late infections after human bone marrow transplantation: role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. , 1982, Blood.

[684]  K. K. Ogilvie,et al.  A new nucleoside analog, 9-[[2-hydroxy-1-(hydroxymethyl)ethoxyl]methyl]guanine, highly active in vitro against herpes simplex virus types 1 and 2 , 1982, Antimicrobial Agents and Chemotherapy.

[685]  N. Flournoy,et al.  Intravenous acyclovir to treat mucocutaneous herpes simplex virus infection after marrow transplantation: a double-blind trial. , 1982, Annals of internal medicine.

[686]  O. Laskin,et al.  Acyclovir prophylaxis of herpes-simplex-virus infections. , 1981, The New England journal of medicine.

[687]  M. Piazza,et al.  HEPATITIS B NOT TRANSMISSIBLE VIA FÆCAL-ORAL ROUTE , 1975, The Lancet.

[688]  M. Mahl,et al.  Virus survival on inanimate surfaces. , 1975, Canadian journal of microbiology.

[689]  W. Hillis,et al.  Adenovirus infections in West Bengal. I. Persistence of viruses in infants and young children. , 1973, The Indian journal of medical research.

[690]  A. Levine,et al.  Transmission of toxoplasmosis by leukocyte transfusion. , 1971, Blood.

[691]  J. E. Phillips,et al.  Pneumocystis pneumonia transmission between patients with lymphoma. , 1969, JAMA.

[692]  J. Remington,et al.  The compromised host and infection. I. Pneumocystis carinii pneumonia. , 1967, JAMA.

[693]  S. K. Mcilvanie,et al.  PNEUMOCYSTIS CARINII PNEUMONIA IN A FAMILY. , 1965, JAMA.

[694]  G. Edsall.  PASSIVE IMMUNIZATION. , 1963, Pediatrics.

[695]  Sanjay Saint,et al.  Guidelines for the prevention of intravascular catheter-related infections. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[696]  Iraida E. Robledo,et al.  Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. , 2009, MMWR. Morbidity and mortality weekly report.

[697]  Médecine Santé-Voyage.  An Advisory Committee Statement (ACS) , 2009 .

[698]  U. Wu.  Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: Performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay , 2009 .

[699]  M. Martelli,et al.  NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. , 2008, Blood cells, molecules & diseases.

[700]  J. Beaumont,et al.  Universal Surveillance for Methicillin-Resistant Staphylococcus aureus in 3 Affiliated Hospitals , 2008, Annals of Internal Medicine.

[701]  D. Scadden,et al.  Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020. , 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[702]  A. Bacigalupo,et al.  Lymphocyte subsets recovery following allogeneic bone marrow transplantation (BMT): CD4+ cell count and transplant-related mortality , 2008, Bone Marrow Transplantation.

[703]  John R Perfect,et al.  Resistance to Antifungal Agents: Mechanisms and Clinical Impact , 2008 .

[704]  J. Talmadge.  Lymphocyte subset recovery following allogeneic bone marrow transplantation: CD4+-cell count and transplant-related mortality , 2008, Bone Marrow Transplantation.

[705]  C. Dye,et al.  World Malaria Report, 2008. , 2008 .

[706]  S. Dessain,et al.  Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. , 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[707]  E. Kimby,et al.  Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus , 2007, Leukemia.

[708]  N. Jin,et al.  Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[709]  A. Menasalvas,et al.  Influence of harvest bacterial contamination on autologous peripheral blood progenitor cells post-transplant , 2007, Bone Marrow Transplantation.

[710]  M. Falagas,et al.  Probiotics for the treatment of women with bacterial vaginosis , 2007 .

[711]  A. Rojiani,et al.  Two cases of progressive multifocal leukoencephalopathy after allogeneic hematopoietic cell transplantation and a review of the literature , 2007, Bone Marrow Transplantation.

[712]  Interferon gamma release assays for latent tuberculosis infection. An Advisory Committee Statement (ACS). , 2007, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[713]  Blood donor screening for chagas disease--United States, 2006-2007. , 2007, MMWR. Morbidity and mortality weekly report.

[714]  Eliete da Cunha Araújo,et al.  Safety, immunogenicity, and protective efficacy of two doses of RIX4414 live attenuated human rotavirus vaccine in healthy Brazilian infants Segurança, imunogenicidade e eficácia protetora de duas doses da vacina RIX4414 contendo rotavírus atenuado de origem humana , 2007 .

[715]  W. Knowles.  Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). , 2006, Advances in experimental medicine and biology.

[716]  P. Ljungman,et al.  Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation. , 2006, Haematologica.

[717]  J Mackenzie,et al.  Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. , 2006, Vox sanguinis.

[718]  K. Kashima,et al.  Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. , 2006, The Journal of infectious diseases.

[719]  C. Tzeng,et al.  Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[720]  A new product (VariZIG) for postexposure prophylaxis of varicella available under an investigational new drug application expanded access protocol. , 2006, MMWR. Morbidity and mortality weekly report.

[721]  K. Castro,et al.  Prevention and control of tuberculosis in correctional and detention facilities: recommendations from CDC. Endorsed by the Advisory Council for the Elimination of Tuberculosis, the National Commission on Correctional Health Care, and the American Correctional Association. , 2006, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[722]  M. Boccadoro,et al.  Corticosteroids can reverse severe imatinib-induced hepatotoxicity. , 2006, Haematologica.

[723]  L. Mascola,et al.  Chagas disease after organ transplantation--Los Angeles, California, 2006. , 2006, MMWR. Morbidity and mortality weekly report.

[724]  B. Thiers.  A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older Adults , 2006 .

[725]  H. Einsele,et al.  Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[726]  S. Nakao,et al.  High incidence of cytomegalovirus reactivation in adult recipients of an unrelated cord blood transplant. , 2005, Haematologica.

[727]  D. Biesma,et al.  Development of functional Haemophilus influenzae type b antibodies after vaccination. , 2005, Haematologica.

[728]  F. Baldanti,et al.  Rising antigenemia levels may be misleading in pre-emptive therapy of human cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients. , 2005, Haematologica.

[729]  C. Mackall,et al.  Age-dependent incidence, time course, and consequences of thymic renewal in adults. , 2005, The Journal of clinical investigation.

[730]  C. Diamond,et al.  Malignancy‐related causes of death in human immunodeficiency virus‐infected patients in the era of highly active antiretroviral therapy , 2005, Cancer.

[731]  DAVID M. SOULELES,et al.  Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[732]  A. Limaye,et al.  Polyomavirus nephropathy in native kidneys of non-renal transplant recipients. , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[733]  E. Sondik,et al.  Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2005, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[734]  R. Storb,et al.  Hepatic injury after nonmyeloablative conditioning followed by allogeneic hematopoietic cell transplantation: a study of 193 patients. , 2004, Blood.

[735]  S. Rivella,et al.  Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease. , 2004, Best practice & research. Clinical haematology.

[736]  M. Loeb,et al.  The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper. , 2004, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

[737]  J. M. Fernández,et al.  Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation. , 2004, Haematologica.

[738]  Transfusion-associated transmission of West Nile virus--Arizona, 2004. , 2004, MMWR. Morbidity and mortality weekly report.

[739]  Outbreak of histoplasmosis among industrial plant workers--Nebraska, 2004. , 2004, MMWR. Morbidity and mortality weekly report.

[740]  C. Bridges,et al.  Prevention and control of influenza : recommendations of the Advisory Committee on Immunization Practices (ACIP) , 2004 .

[741]  D. Kovacevich,et al.  Guidelines for the prevention of intravascular catheter-related infections: Centers for Disease Control and Prevention. , 2003, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[742]  I. Raad,et al.  Minocycline-ethylenediaminetetraacetate lock solution for the prevention of implantable port infections in children with cancer. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[743]  R. Gunning,et al.  Gauze and tape and transparent polyurethane dressings for central venous catheters. , 2003, The Cochrane database of systematic reviews.

[744]  J. Lowder,et al.  Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact. , 2003, Cytotherapy.

[745]  D. Gastineau,et al.  Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapy. , 2003, Cytotherapy.

[746]  J. Steiger,et al.  Polyomavirus BK. , 2003, The Lancet. Infectious diseases.

[747]  R. Storb,et al.  Review of “Minitransplantation”: Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation , 2003, International journal of hematology.

[748]  D. Eisen,et al.  Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy , 2003, Bone Marrow Transplantation.

[749]  L. Tanoue.  Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection—United States, 2003 , 2006 .

[750]  D. Fleming,et al.  Outbreaks of Salmonella serotype enteritidis infection associated with eating shell eggs--United States, 1999-2001. , 2003, MMWR. Morbidity and mortality weekly report.

[751]  Detection of West Nile virus in blood donations--United States, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[752]  Update: Detection of West Nile virus in blood donations--United States, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[753]  A. Comrie,et al.  Increase in coccidioidomycosis--Arizona, 1998-2001. , 2003, MMWR. Morbidity and mortality weekly report.

[754]  R. Arafat,et al.  Probable transfusion-transmitted malaria--Houston, Texas, 2003. , 2003, MMWR. Morbidity and mortality weekly report.

[755]  N. Ueno,et al.  Nonmyeloablative preparative regimens for allogeneic hematopoietic transplantation. Biology and current indications. , 2003, Oncology.

[756]  M. Exner,et al.  Role of increased environmental Aspergillus exposure for patients with chronic obstructive pulmonary disease (COPD) treated with corticosteroids in an intensive care unit. , 2002, International journal of hygiene and environmental health.

[757]  C. Pannuti,et al.  Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil. , 2002, Blood.

[758]  Investigation of blood transfusion recipients with West Nile virus infections. , 2002, MMWR. Morbidity and mortality weekly report.

[759]  Chagas disease after organ transplantation--United States, 2001. , 2002, MMWR. Morbidity and mortality weekly report.

[760]  Robert E. Johnson,et al.  From the Centers for Disease Control. Staphylococcus aureus resistant to vancomycin--United States, 2002. , 2002, JAMA.

[761]  T. Calandra,et al.  Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer , 2002 .

[762]  J. Freedman,et al.  Proceedings of a consensus conference: prevention of post-transfusion CMV in the era of universal leukoreduction. , 2001, Transfusion medicine reviews.

[763]  M. Kiehl,et al.  Toxoplasmosis, a severe complication in allogeneic hematopoietic stem cell transplantation: successful treatment strategies during a 5-year single-center experience. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[764]  P. Ruutu,et al.  Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients , 2001, Bone Marrow Transplantation.

[765]  H. Akan,et al.  Aerobic bacterial and fungal infections in peripheral blood stem cell transplants , 2001, Bone Marrow Transplantation.

[766]  S. Kvaløy,et al.  Humoral immunity to viral and bacterial antigens in lymphoma patients 4–10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines , 2001, Bone Marrow Transplantation.

[767]  Atlanta,et al.  Morbidity and Mortality Weekly Report , 2006 .

[768]  Gorbach,et al.  Where Have All the Case Reports Gone? , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[769]  T. Horan,et al.  Guideline for prevention of surgical site infection. , 2000, Bulletin of the American College of Surgeons.

[770]  Dallas,et al.  Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2000, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[771]  T. C. White,et al.  Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole. , 2000, The Journal of infectious diseases.

[772]  M. Vasconcelles,et al.  Aerosolized pentamidine as pneumocystis prophylaxis after bone marrow transplantation is inferior to other regimens and is associated with decreased survival and an increased risk of other infections. , 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[773]  K. Kain,et al.  Transfusion-transmitted babesiosis in Ontario: first reported case in Canada. , 2000, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[774]  ohnson,et al.  USE OF THE SELECTIVE ORAL NEURAMINIDASE INHIBITOR OSELTAMIVIR TO PREVENT INFLUENZA , 2000 .

[775]  K. Atkinson.  Clinical bone marrow and blood stem cell transplantation , 2000 .

[776]  N. Cox.  Prevention and control of influenza. , 1999, Lancet.

[777]  G. Barker.  Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation , 1999, Supportive Care in Cancer.

[778]  H. Heslop,et al.  Transfer of EBV‐specific CTL to prevent EBV lymphoma post bone marrow transplant , 1999, Journal of clinical apheresis.

[779]  A P Gee,et al.  Product release assays. , 1999, Cytotherapy.

[780]  S. Heimfeld,et al.  Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. , 1999, Blood.

[781]  Outbreak of cryptosporidiosis associated with a water sprinkler fountain--Minnesota, 1997. , 1999, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[782]  M. Boeckh,et al.  Occult cytomegalovirus infection of marrow stroma. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[783]  S. Glück,et al.  Bacterial decontamination of blood stem cell apheresis products , 1998, Journal of clinical apheresis.

[784]  M H Kramer,et al.  First reported outbreak in the United States of cryptosporidiosis associated with a recreational lake. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[785]  D. Srivastava,et al.  Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. , 1998, Blood.

[786]  Outbreak of acute febrile illness among athletes participating in triathlons--Wisconsin and Illinois, 1998. , 1998, MMWR. Morbidity and mortality weekly report.

[787]  E. Stiehm.  Human intravenous immunoglobulin in primary and secondary antibody deficiencies. , 1997, The Pediatric infectious disease journal.

[788]  E. Todd.  Epidemiology of foodborne diseases: a worldwide review. , 1997, World health statistics quarterly. Rapport trimestriel de statistiques sanitaires mondiales.

[789]  S. Waterman,et al.  Outbreak of leptospirosis among white-water rafters--Costa Rica, 1996. , 1997, MMWR. Morbidity and mortality weekly report.

[790]  Sustained transmission of nosocomial Legionnaires disease--Arizona and Ohio. , 1997, MMWR. Morbidity and mortality weekly report.

[791]  Randolph L. Gordon,et al.  Immunization of health-care workers: recommendations of the Advisory Committee on Immunization Practices (ACIP) and the Hospital Infection Control Practices Advisory Committee (HICPAC). , 1997, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[792]  P. Strebel,et al.  Poliomyelitis prevention in the United States: new recommendations for routine childhood vaccination place greater reliance on inactivated poliovirus vaccine. , 1997, Pediatric annals.

[793]  S. Woo,et al.  Graft-vs.-host disease. , 1997, Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists.

[794]  Update: Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997. , 1997, MMWR. Morbidity and mortality weekly report.

[795]  R. Glass,et al.  The changing epidemiology of astrovirus-associated gastroenteritis: a review. , 1996, Archives of virology. Supplementum.

[796]  S. Hewitt,et al.  The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. , 1996, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[797]  Lake-associated outbreak of Escherichia coli O157:H7--Illinois, 1995. , 1996, MMWR. Morbidity and mortality weekly report.

[798]  K. Carroll,et al.  Surveillance cultures in bone marrow transplant recipients: worthwhile or wasteful? , 1995, Bone marrow transplantation.

[799]  F. Hayden,et al.  Orthomyxoviral and paramyxoviral infections in transplant patients. , 1995, Infectious disease clinics of North America.

[800]  J. Englund,et al.  Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. , 1995, Bone marrow transplantation.

[801]  Recommendations for preventing the spread of vancomycin resistance. Hospital Infection Control Practices Advisory Committee. , 1995, Emerging infectious diseases.

[802]  USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus: a summary. , 1995, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[803]  D. Fleming,et al.  Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). , 1995, American journal of infection control.

[804]  C. Glaser,et al.  Animal-associated opportunistic infections among persons infected with the human immunodeficiency virus. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[805]  F. Mandelli,et al.  Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. , 1994, Lancet.

[806]  A. Nagler,et al.  Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. , 1993, Bone marrow transplantation.

[807]  A. Vellodi,et al.  Transmission of toxoplasmosis by bone marrow transplant associated with Campath-1G. , 1992, Bone marrow transplantation.

[808]  J. R. Johnson,et al.  Hepatitis due to herpes simplex virus in marrow-transplant recipients. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[809]  E. Duncan,et al.  Aspergillus fumigatus sternal wound infections in patients undergoing open heart surgery. , 1992, American journal of epidemiology.

[810]  K. Sullivan,et al.  Late complications of allogeneic and autologous marrow transplantation. , 1992, Bone marrow transplantation.

[811]  Favero.  Sterilization, disinfection, and antisepsis in the hospital , 1991 .

[812]  J. Niland,et al.  A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group. , 1991, The New England journal of medicine.

[813]  Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. , 1991, The Journal of the Michigan Dental Association.

[814]  Recommendations for preventing transmission of human immunodeficiency virus and hepatitis B virus to patients during exposure-prone invasive procedures. , 1991, AORN journal.

[815]  T. Walsh,et al.  Role of surveillance cultures in prevention and treatment of fungal infections. , 1990, NCI monographs : a publication of the National Cancer Institute.

[816]  A. Bloch.  Nutrition management of the cancer patient , 1990 .

[817]  Ruth B. Kundsin,et al.  Architectural design and indoor microbial pollution , 1988 .

[818]  E. H. Lennette.  Laboratory diagnosis of viral infections , 1985 .

[819]  Standards for blood banks and transfusion services. , 1977, QRB. Quality review bulletin.

[820]  W. Nyhan,et al.  Haemophilus influenzae infections. , 1972, The New England journal of medicine.

[821]  L. Elveback,et al.  The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness. , 1969, American journal of epidemiology.

[822]  M. Kaji.  [ADENOVIRUS INFECTIONS]. , 1964, Fukuoka igaku zasshi = Hukuoka acta medica.

[823]  K. Edwards,et al.  Infection Control and Hospital Epidemiology Duration of Virus Shedding after Trivalent Intranasal Live Attenuated Influenza Vaccination in Adults , 2022 .

[824]  Steven D. Brown,et al.  Annals of Clinical Microbiology and Antimicrobials Open Access Trends in Antibacterial Resistance among Streptococcus Pneumoniae Isolated in the Usa: Update from Protekt Us Years 1–4 , 2022 .